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FORWARD: 
 
In this dissertation I will present data I have collected regarding mechanistic testing of the 
novel hypothesis that TE activity drives neurodegenerative decline in a subset of neurodegenerative 
diseases. Specifically, I will demonstrate that TDP-43 pathology, which is highly implicated in the 
etiology of a spectrum of neurodegenerative diseases that spans ALS and FTLD, induces loss of 
suppression of TEs. This likely occurs via TDP-43-dependent degradation of the somatic, post-
transcriptional TE silencing mechanism. I will show that TDP-43-dependent TE activation causally 
contributes to physiological decline. Further, I will demonstrate that apoptosis induced by TDP-43 
expression is largely mediated by Chk-2 signaling following DNA damage, that DNA damage-
mediated apoptosis accounts for much of the toxicity experienced by animals that express hTDP-43, 
and that TE activation at least partially contributes to this DNA damage-mediated apoptosis. Finally, I 
will use the data presented herein, recent reports from the literature, and other recent work from the 
Dubnau lab to build a model by which to interpret the pathological activation of TEs in the context of 
both normal neurological decline in wild type aging and in the case of TDP-43 protein pathologies. I 
believe this exercise is likely to prove beneficial to understanding neurodegenerative disease more 
generally, as TEs have recently been reported to be involved in several other non-TDP-43 related 
neurodegenerative diseases as well. In order to understand how and why TEs run amok in the aged 
CNS, however, we must first understand the nature of TEs. This requires more than a simple 
definition of their genomic features; we must explore the relationship between eukaryotic genomes 
and their TE residents, the role TEs have played in shaping their host genomes and new findings 
suggesting that the nervous system specifically has made particular use of TEs. Only then can we 
place TE activity in the context of normal organismal aging, and begin to address the reasons why 
they may be particularly susceptible to disregulation in the aged nervous system.
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CHAPTER 1 – Introduction: 
 
 
TEs are ubiquitous, characteristic features of eukaryotic genomes - mobile genetic elements 
that are capable of replicating themselves via translocation to novel positions in the genome, thus 
ensuring their continued propagation (Kidwell and Lisch 2001; Brookfield 2005). When allowed to 
transpose freely, they pose a threat to genome stability by insertional mutagenesis, creating double-
stranded DNA breaks, and inducing large-scale genomic duplications, inversions, and deletions 
(Symer et al. 2002). Eukaryotic organisms have therefore developed interleaved co-transcriptional 
and post-transcriptional mechanisms by which to ensure TE suppression at inappropriate times 
(Castel and Martienssen 2013). However, both the raw genomic sequence of TEs and the epigenetic 
mechanisms that suppress them appear to have been co-opted by their host genomes to serve 
functions in eukaryotic genome architecture and regulation (Slotkin and Martienssen 2007; Feschotte 
2008). This section will begin with a brief overview of the classes of TEs and the mechanisms that 
eukaryotic systems use to suppress them. I will then elaborate how mobile elements may have 
facilitated the evolution of the linear chromosome by contributing to centromere and telomere 
function and the role TEs play in X chromosome-inactivation in placental mammals. I will follow up 
by describing how the genomic revolution has enabled further elucidation of the myriad ways in 
which TEs have been exapted for genome regulation in eukaryotes, with a particular emphasis on 
recent advances in understanding the role TE-derived CNCS plays in regulating the deployment of 
genetic information, and how TE-driven innovation in these regions may influence morphological and 
neurological diversity within the vertebrate lineage. Finally, I will discuss our current understanding 
of the ways in which TEs have been implemented to solve unique biological problems at the 
organismal level with regard to responding to and interacting with the environment. This includes the 
well-delineated and distinctive V(D)J recombination mechanism that enables the acquired immune 
system to adapt to a near-endless and unpredictable influx of foreign antigens, and the more newly  
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FIGURE 1. Classes of TEs and mechanisms of transposition. 
Classes of TEs: (A) DNA transposons (Class II), (B) LTR and (C) Non-LTR RTEs (Class I) [adapted 
from: (Feschotte 2008)].  
Mechanisms of transposition: (D) ‘cut and paste’ replication, (E) ‘copy and paste’ replicative 
transposition, and (F) ‘copy and paste’ target site-primed reverse transcription [adapted from: (Levin 
and Moran 2011)]. 
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described phenomenon of L1 mobilization during neurodevelopment, which results in somatic 
mosaicism in the adult mammalian brain. As this regulated phenomenon appears to be highly active 
in brain, with differing levels of somatic transposition in different cell types and de novo insertions 
frequently appearing in close proximity to genes important for nervous system function (Muotri et al. 
2005; Coufal et al. 2009; Kuwabara et al. 2009; Muotri et al. 2009; Baillie et al. 2011; Perrat et al. 
2013; Upton et al. 2015), it appears that the nervous system has, like so many other facets of 
eukaryotic biology, made use of the complexity-building functionality of TEs to perform intricate 
biological tasks. 
 
I. Transposition Mechanisms and Suppression Systems: 
TEs can be classified using two sets of criteria. The most common relies on whether the element 
requires RT activity for mobilization. Elements that require RT activity are called Class I elements, or 
RTEs (Slotkin and Martienssen 2007) (Figure 1B and 1C). These elements mobilize via a duplicative 
“copy-and-paste” mechanism in which they pass through an RNA intermediate, generating a new 
copy of the element with every transposition event (Figure 1E and 1F). Class I elements can be 
further divided into LTR or non-LTR elements, depending on whether they have LTRs flanking their 
termini (Figure 1B and 1C). All LTR elements encode Gag and Pol proteins comparable to exogenous 
retroviruses, but lack the Env protein required for cell exodus. Those RTEs that do encode an Env are 
denoted ERVs based on their more complete structural homology to exogenous retroviruses (Slotkin 
and Martienssen 2007). TEs that do not require RT activity for mobilization are termed Class II 
elements, or DNA TEs. These elements generally encode a transposase enzyme capable of excising 
the element by recognizing the TIRs at its flanking ends and subsequently inserting the element into a 
novel position in the genome (Figure 1A). This mechanism is referred to as “cut-and-paste,” and 
frequently leaves behind traces of the element’s presence in the form of truncated or duplicated TIR 
sequences (Slotkin and Martienssen 2007) (Figure 1D). TEs can also be classified based on whether 	
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FIGURE 2. TE composition of the human genome.  
[adapted from: (Cordaux and Batzer 2009)]. 
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they are capable of self-mobilization. The types of elements listed above encode all of the protein	machinery	required	to	transpose,	and	are	therefore	termed	“autonomous	elements.”	Elements 
containing cis regulatory sequences recognized by the machinery of autonomous TEs may also 
proliferate throughout the genome in trans despite their own lack of encoded enzymes (Figure 1A – 
1C). Such non-autonomous TEs include SINEs, such as Alu elements in primates (Dewannieux et al. 
2003; Garcia-Perez et al. 2007a; Garcia-Perez et al. 2007b) and B2 elements in rodents, and MITEs, 
which consist of minimal intervening sequence adjoined by two TIRs (Slotkin and Martienssen 
2007).  
TE mobilization poses an immense threat to the host genome, capable of causing insertional 
mutations in coding sequences upon arrival, gross chromosomal abnormalities such as large-scale 
inversions and deletions, and RNA-level toxicity (Kazazian and Goodier 2002; Symer et al. 2002; 
Kaneko et al. 2011). Given the trans activating faculty of transposition machinery and the large 
amount of real estate they possess in the host genome (Cordaux and Batzer 2009) (Figure 2), it is easy 
to imagine a scenario in which unchecked run-away transposition completely destroys the host 
genome. However, such a scenario would be advantageous to neither the host nor to the TEs 
involved, as their survival relies on being passed from the host to its progeny. As such, eukaryotic 
organisms have evolved several multilayered mechanisms by which to control and suppress 
inappropriate transposition. The first consists of epigenetic chromosome-level silencing, including 
repressive chromatin modifications and even DNA methylation in vertebrates (see below). The 
second line of defense acts post-transcriptionally and usually relies on base complementarity between 
a small RNA “guide” molecule and the TE transcript to localize RNA degradation machinery to the 
TE transcript and destroy it before it completes the transposition cycle. 
The germ line, which is sequestered early in development (Slotkin and Martienssen 2007), has 
developed a particular small RNA-based silencing system, collectively called the PIWI-piRNA 
complex, to shield progeny against specific elements previously experienced within their parental 
lineage (Figure 3). This system capitalizes on sequence similarity between active TE transcripts and  
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FIGURE 3. small RNA silencing systems in Drosophila. 
Schematic representations of the components of the piRNA, miRNA, endo- and exo-siRNA pathways 
in Drosophila melanogaster [adopted from: (Ghildiyal and Zamore 2009)].  
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transcripts from piRNA clusters; numerous stretches of genomic DNA of assorted lengths ranging 
from 1-100 kilobases within which are embedded residual sequence from past transposition events in	various	orientations	(Slotkin	and	Martienssen	2007).	As	integration	of novel TEs into piRNA 
clusters results in the creation of new piRNAs (Olovnikov et al. 2013), this system can be thought of 
as a type of “acquired immunity” for the organism against the TE residents of its genome (Slotkin and 
Martienssen 2007). In Drosophila, antisense transcripts derived from piRNA clusters are loaded onto 
the PIWI-clade Argonaute protein Aub, which recognizes and cleaves complementary TE transcripts 
in the cytoplasm, thus recruiting them into the “ping-pong” amplification cycle in conjunction with 
Argonaute 3 to effectively amplify the antisense piRNA arsenal (Slotkin and Martienssen 2007; 
Aravin and Hannon 2008; Castel and Martienssen 2013) (Figure 3). This mechanism endows the 
system with inherent robustness and redundancy that ensures against excessive de novo mutagenesis 
of the next generation. It should be noted that any sequence complementary to the piRNA might 
operate in this mechanism; therefore a piRNA generated from sequence common to a TE family may 
silence transcripts from all family members (Kavi et al. 2005). While not identical across species, 
analogous PIWI-piRNA complex mechanisms have been found across both vertebrates and 
invertebrates, suggesting that they perform a convergent function (Castel and Martienssen 2013). 
Indeed, piRNA clusters are known to appear in syntenic locations in the mouse and human genome 
but are divergent in sequence (Girard et al. 2006), signifying both their conserved function and 
lineage specificity. 
While the PIWI-piRNA complex governs TE protection in the germline, another small RNA 
system defends somatic tissue against unwanted nucleic acid species. The siRNA or RNAi pathway is 
triggered by dsRNA, which may be generated by TE transcripts, convergent transcription or 
transcription of other types of structured loci, or by exogenous virus infection (Figure 3). Perfectly 
base paired dsRNA is recognized by a Dicer family member, which processively cleaves the dsRNA 
into 21-30 nucleotide siRNAs (Okamura and Lai 2008). These siRNAs are distinguishable from  
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FIGURE 4. Co-transcriptional and post-transcriptional mechanisms of RNAi. 
(A) siRNA-mediated PTGS in Drosophila melanogaster; (B) siRNA-mediated CTGS as delineated in 
Arabidopsis thaliana [adopted from: (Buhler et al. 2006)]. 
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piRNA species based on differences in length and end modifications (Vagin et al. 2006). One strand 
of this siRNA duplex is then loaded onto an Argonaute family member, forming the core of the RISC, 
where the siRNA guide molecule recognizes the target RNA species via sequence complementarity 
and the slicer activity of the Argonaute protein hydrolyzes the target, resulting in RNA degradation  
(Figure 3). TEs have been observed to produce siRNAs in many species (Vagin et al. 2006; Slotkin 
and Martienssen 2007; Ghildiyal and Zamore 2009), and TE-siRNA levels have been shown to affect 
TE activity (Lippman et al. 2003; Sijen and Plasterk 2003; Yang and Kazazian 2006; Slotkin and 
Martienssen 2007). Disrupting the siRNA pathway results in increased TE transcripts (Svoboda et al. 
2004; Czech et al. 2008; Li et al. 2013) as well as increased novel insertions in the genome (Li et al. 
2013; Xie et al. 2013). While there have been reports of PIWI family member protein expression in 
somatic tissue and correlation between expression of these proteins and TE activity (Perrat et al. 
2013), the body of evidence indicates that the siRNA pathway is primarily responsible for silencing 
TEs in somatic tissue. Given that the siRNA-RISC complex acts on cytoplasmic RNA species, this 
system is generally referred to as PTGS (Castel and Martienssen 2013) (Figure 4A). 
Members of the RNAi pathway can also participate in CTGS in which the RITS is recruited to 
nascent transcripts again via sequence complementarity to a guide siRNA (Castel and Martienssen 
2013) (Figure 4B). RITS was first discovered in the fission yeast, Schizosaccharomyces pombe, 
where the RITS complex is composed of an siRNA-loaded Argonaute protein as well as the 
Argonaute- and chromatin-interacting protein Tas3 and the chromodomain protein Chp2, which 
assists in localizing RITS to heterochromatin via binding to H3K9me (Verdel et al. 2004; Buhler et 
al. 2006). RITS in turn recruits factors that generate repressive chromatin structures, including a 
methyltransferase, a histone deacetylase, and an HP1 ortholog (Buhler et al. 2006). RITS is believed 
to act via a feed-forward mechanism such that its association with heterochromatin couples with 
dsRNA synthesis to reinforce or even to spread heterochromatic marks (Buhler et al. 2006; Castel and 
Martienssen 2013) (Figure 4B). Importantly, both read-through transcription and Argonaute’s slicer  
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FIGURE 5. The destructive effects of un-checked transposition: P-element hybrid dysgenesis in 
Drosophila. 
(A) Hybrid dysgenic cross, female F1 progeny are sterile; (B) reciprocal cross, female F1 progeny are 
fully fertile [adapted from: (Siomi et al. 2011)]. (C) Ovaries of hybrid dysgenic F1 female progeny 
are completely destroyed, while (D) ovaries of the F1 female progeny from the reciprocal cross 
develop normally [adapted from: (Schaefer et al. 1979)]. 
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activity are required for nucleation and spreading of heterochromatin, at least in S pombe (Irvine et al. 
2006). This mechanism seems to be generally conserved across Eukarya, as components of the 
piRNA pathway – including Piwi, Aub, and Spindle-E - have all been implicated in heterochromatic 
gene silencing in Drosophila (Pal-Bhadra et al. 1999; Pal-Bhadra et al. 2002; Kogan et al. 2003; Pal-
Bhadra et al. 2004; Kanellopoulou et al. 2005), while CTGS of endogenous promoters by synthetic 
shRNAs has been observed in mammalian cells (Morris et al. 2004; Taira 2006). 
A remarkable example of the destructive potential of unchecked TE activity is the phenomenon of 
hybrid dysgenesis in the fruit fly, Drosophila melanogaster (Figure 4). This system relies on the 
activity of piRNAs in the germline, which are maternally inherited in the fly (Castro and Carareto 
2004). As previously mentioned, piRNAs act as a type of acquired immunity for the F1 progeny 
against those TEs experienced in the mother’s genome and her predicessors. Therefore, if a cross is 
set up in which the mother is carrying a specific TE, in this case the P-element TE, but the male is 
not, the F1 progeny receive both the P-element and the piRNA immunity against it. Their ovaries 
develop normally and they are perfectly fertile (Schaefer et al. 1979; Castro and Carareto 2004) 
(Figure 5B and 5D). However, if the reciprocal hybrid dysgenic cross is set up in which the parental 
male carries P-element but the parental female does not, the F1 progeny still receive the P-element 
but do not receive any piRNAs directed against P-element because it was not present in the mother’s 
genome. In this case the female F1 progeny are infertile and, in fact, the tissue of their ovaries is 
completely destroyed (Schaefer et al. 1979; Castro and Carareto 2004; Brennecke et al. 2008) (Figure 
5A and 5C). 
 Eukaryotes rely on interleaved mechanisms to control TE mobilization, all commonly 
organized around the basic concept of implementing base pairing interactions of a short RNA species 
to guide enzyme activity in order to inactivate the element, be it at the level of transcript degradation 
or repressive chromatin organization. However, mutation of existing elements or acquisition of new 
elements renders them essentially invisible to the host’s surveillance machinery, consequently 
allowing them to transpose freely. Furthermore, it seems that TEs are not absolutely silenced. The  
	 43	
  
	 44	
CTGS process actually requires transcription (Irvine et al. 2006; Castel and Martienssen 2013), while 
novel germline insertions of TEs are commonly observed in genomic sequences from different 
individuals (Deininger and Batzer 2002; Ostertag et al. 2003). When this happens, such elements 
provide the genetic variability substrate to be acted on by natural selection (Zhu et al. 2014). 
 
II. Exaption of Transposable Elements: 
Britten and Kohne were the first to demonstrate that eukaryotic genomes are comprised of 
two distinct subpopulations (Britten and Kohne 1968). This was determined by plotting the kinetics 
of DNA reassociation on a “COT-curve,” where the fraction of reassociated DNA is plotted against 
the parameter COT, which represents the product of the DNA concentration in the solution times the 
time of incubation (moles of DNA by seconds per liter). A rapidly reassociating, repetitive fraction 
and a much more slowly reassociating, non-repetitive fraction were observed. The two authors further 
explored evolutionary relationships in DNA reassociation rates, finding that reassociated strands of 
DNA from different species display decreasing thermal stability the longer the two species have been 
separated in evolutionary time (Britten and Kohne 1968). From this work they determined that 
mammalian genomes are composed of an estimated 20-35% repetitive DNA – a gross 
underestimation in comparison to what we know today, but vastly more than was accepted at the time 
(Marino-Ramirez et al. 2005). Britten and colleagues were some of the first, and loudest, advocates 
that such repetitive DNA would serve some type of structural or regulatory role, roundly admonishing 
the conceptualization of repetitive DNA as “junk” (Britten and Kohne 1968; Britten and Davidson 
1969; Marino-Ramirez et al. 2005). There was just too much of it, conserved across too many highly 
divergent species, for it to simply be left behind by neutral evolutionary drift. 
The terms “mutable loci,” “unstable genes,” and “position effects” had all been used in 
reference to various mysterious genic effects in Drosophila before 1950 (McClintock 1984), but the 
seminal work of Barbara McClintock identified the genetic factors responsible for these phenotypes. 
She termed them “controlling elements” based on their ability to influence the expression of  
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neighboring pigment genes in Zea mays (McClintock 1950). These elements have been popularized 
as “selfish” or “parasitic” elements, a reputation that was only imparted to them in the late 1980’s as a 
greater understanding of the dangers these elements can pose to their host began to be further 
understood (Doolittle and Sapienza 1980; Orgel and Crick 1980; Hickey 1982; Schmid 2003). It is 
inherent in their nature that their unbounded activity be negatively correlated with host fitness 
(Slotkin and Martienssen 2007), and that their relative evolutionary success be founded on their 
replication occurring at a faster rate than the host genome that carries them (Kidwell and Lisch 2001; 
Brookfield 2005). However, it is also true that they have become dependent on their hosts for their 
propagation, therefore any system in which their proliferation is allowed to exceed the bounds of host 
tolerance probably has not withstood the test of evolutionary time. 
The dynamics of the host-TE interaction affect our ability to observe and document the 
process, as current techniques can only capture a static picture of one instant in time. As such, our 
vision is clouded by recent transposition events, which have yet to be acted on by natural selection 
and therefore have, as yet, to reveal the ways in which they may prove beneficial to the host; while 
more ancient events – particularly those derived from now-defunct founder elements – begin to have 
their identifying features wiped away by neutral mutations until they are all but unrecognizable 
(Feschotte 2008). However, advances in comparative genomics have gleaned some insight into the 
multitudinous roles these enigmatic elements play in the regulation of our genome, and their primacy 
in the evolution of eukaryotic genomes as we observe them today. 
II.1: TEs in Genome Evolution:  
TEs may provide the substrate for epigenetic regulatory invention in genome evolution as 
conspicuous similarities can be drawn between epigenetic mechanisms used to repress TEs and those 
employed by the eukaryotic cell to regulate chromosome function. Epigenetic modifications can 
occur at one of two levels – the first is at the level of the histone proteins, which package and 
organize DNA inside the nucleus. Histones have N-terminal tails rich in lysine residues that are  
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targets of post-translational modifications, including acetylation, methylation, and phosphorylation, 
which are often collectively referred to as the “histone code” in reference to their combinatorial 
implementation (Wood et al. 2010; Rothbart and Strahl 2014). Such modifications may then either 
recruit TFs and polymerases to promote transcription in the case of activating modifications, usually 
found in areas of “open” euchromatin, or recruit repressive chromatin complexes in the case of 
repressive modifications in areas of “closed” heterochromatin (Slotkin and Martienssen 2007; Wood 
et al. 2010; Castel and Martienssen 2013; Rothbart and Strahl 2014). Repressive histone 
modifications such as H3 lysine 9 methylation (H3K9me) are often found to be associated with TEs, 
and RNAi components are required for the nucleation and spread of heterochromatin (Slotkin and 
Martienssen 2007). The second form of epigenetic modification that can occur in many organisms is 
cytosine methylation of the DNA sequence itself. These types of modification provides a heritable 
form of “epigenetic memory” due to the ability of symmetrical DNA methylation and histone 
modifications to be passed on to daughter cells after DNA replication and cell division (Yoder et al. 
1997). As TEs are silenced in host cells at both the level of histone modification and DNA 
methylation, it has been hypothesized that TEs may have acted as the chief driving force in epigenetic 
regulatory evolution (Henikoff and Matzke 1997; Miller et al. 1999; Wolffe and Matzke 1999; 
Slotkin and Martienssen 2007), possibly contributing to the two major macroevolutionary transitions 
in the history of life: chromatin formation at the prokaryotic/eukaryotic transition and DNA 
methylation at the invertebrate/vertebrate transition (McDonald 1998; Miller et al. 1999). 
 Such basic roles in chromosome functionality have lead some to suggest that TEs have come 
to comprise key components of the “regulatory toolkit” of the genome (Slotkin and Martienssen 
2007), and perhaps have contributed to evolution of the linear chromosome itself. Indeed, TEs can act 
as nucleation centers for facultative heterochromatin. This type of heterochromatin can propagate 
linearly for up to 10 kilobases, potentially interfering with neighboring genes (Sun et al. 2004). 
Strikingly, the PEV phenomenon (Figure 6A) in which a reporter gene is silenced in some cells and 
not others due to insertion proximity near heterochromatin, resulting in a variegated phenotype, is  
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FIGURE 6. The multifaceted roles TEs perform in maintaining global genomic architecture 
and dosage compensation. 
(A) Position effect variegation in Drosophila; transgene expression is related to insertion site 
proximity to genomic TEs [adapted from: (Slotkin and Martienssen 2007)]. (B) Schematic of TE 
density over the length of the chromosome; high density of TE sequence (red) resides in constitutive 
pericentromeric and peri-telomeric heterochromatin. (C) DICER deficient mouse embryonic stem 
cells demonstrate decondensation of centromeres; DICER deficient cells display notable binding of 
RNA FISH probes to centromeric DNA repeat sequences [adapted from: (Kanellopoulou et al. 
2005)]. (D) Deep evolutionary conservation of telomerase in eukaryotes and its relationship to 
exogenous retroviruses, endogenous RTEs, and group II introns (D.1).  Yeast Schizosaccharomyces 
pombe Trt1p (Sp_Trt1p); Homo sapien TRT (hTRT); ciliate Euplotes aediculatus p123 (Eα_p123); 
and yeast Schisosaccharomyces cerevisiae Est2p (Sc_Est2p). (D.2) Colored domains from (D.1) are 
mapped onto the structure of HIV-1 RT. [adapted from: (Nakamura et al. 1997)]. (E) Longitudinal 
FISH demonstrates close association of L1 transcripts with XIST RNA and subsequent silencing of 
L1 transcription in female embryonic stem cells (E.1). (E.2) Quantification of L1 RNA FISH signal 
near to and within XIST domain over time [adapted from: (Chow et al. 2010)]. 
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dependent on both histone methyltransferases and Argonaute proteins, implicating the same 
underlying RNAi-based silencing mechanisms as those used to silence TEs (Schotta et al. 2003; 
Haynes et al. 2006; Slotkin and Martienssen 2007). Intriguingly, TEs have become integral 
components of the constitutive heterochromatic regions flanking both centromeres and telomeres 
(Figure 6B), whose correct function is absolutely required for the fundamental purposes of trafficking 
chromosomes during cell division and counteracting chromosome truncation following replication, 
respectively (Slotkin and Martienssen 2007). 
 Centromeres generally consist of long tandem arrays of satellite DNA, or simple short 
sequence repeats, which are bounded by pericentric regions enriched for TEs (Dawe and Henikoff 
2006; Slotkin and Martienssen 2007). In humans, the satellite regions are free of TEs while the 
pericentric areas carry long blocks of LINE and SINE elements (Schueler and Sullivan 2006). The 
physical DNA composition of pericentric regions differs across species but generally reflects lineage 
specific TE families; therefore it is the conserved epigenetic context of these regions that imbues 
them with their functionality (Dawe and Henikoff 2006). Current techniques have been unable to 
determine whether TEs preferentially target pericentric regions or whether they simply have a higher 
propensity to be retained there due to a reduced rate of recombination (Dawe and Henikoff 2006; 
Slotkin and Martienssen 2007). It has been shown in S pombe that RNAi mutants accumulate both 
forward and reverse centromeric transcripts (Volpe et al. 2002) while DICER mutant mammalian cell 
lines display both condensation and differentiation defects (Kanellopoulou et al. 2005) (Figure 6C), 
implicating a key role of RNAi in maintaining pericentric heterochromatic structures. Reactivation of 
silenced centromeric TEs has been shown to espouse both chromosome segregation and meiotic 
defects in the mouse (Peters et al. 2001; Bourc'his and Bestor 2004; De La Fuente et al. 2006), while 
an essential role of TEs has been found in maintaining constitutive centromeric heterochromatin in 
both yeast and plants (Slotkin and Martienssen 2007). It remains possible that TEs could have given 
rise to the satellite repeats of centromeres themselves. In many species these tandem repeats have  
  
	 53	
 
  
	 54	
sequence homology to described TEs, although they have lost both their mobility and many structural 
components likely due to functional constraints of this acquired role (Dawe and Henikoff 2006). 
While TEs are also a sizeable component of the constitutive heterochromatin flanking 
telomeres (Slotkin and Martienssen 2007), the RT activity of the telomerase enzyme itself bears a 
striking resemblance to RT enzymes from non-LTR RTEs (Nakamura et al. 1997; Slotkin and 
Martienssen 2007) (Figure 6D.1 and 6D.2). Telomerase displays deep conservation within the 
eukaryotic lineage, through such evolutionarily distant organisms as protozoans, fungi, and mammals, 
suggesting that this activity may have been present among even ancestral eukaryotic founders 
(Nakamura et al. 1997) (Figure 6D.1 and 6D.2). Captivatingly, Drosophila carry two domesticated 
non-LTR RTEs in order to maintain their telomeres, named HeT-A and TART (Pardue et al. 2005). In 
fact, there are many mechanistic similarities between the RNA-templated activity of the telomerase 
ribonucleoprotein and non-LTR retrotransposition. Non-LTR elements are typically reverse 
transcribed directly at the site of integration using nicks in the DNA, usually taking advantage of an 
exposed 3’ hydroxyl to prime reverse transcription directly into the chromosome. Neither telomerase 
RT nor the HeT-A/TART system require nicked DNA, as they are most likely reverse transcribing 
directly onto the end of the chromosome (Eickbush 1997). While telomerase templates are generally 
5-20 nucleotides in length, Drosophila templates consist of the much longer HeT-A and TART 
sequences, resulting in motley head-to-tail arrays of 5’ truncated and full-length elements. The 
similarities between these two systems, and the deeply conserved homology of telomerase RT, beg 
the question of whether retrotransposition or telomerase came first in the evolution of the linear 
chromosome (Eickbush 1997; Miller et al. 1999; Pardue et al. 2005). If, in fact, an ancestral non-LTR 
RTE gave rise to the cellular machinery we now observe to be prerequisite to the replication of linear 
chromosomes, this may be the earliest case of molecular domestication shaping eukaryotic genomes. 
It is curious to consider that Barbara McClintock first described TE activation in response to broken 
chromosome ends, revealing a specific genetic response to this type of genome stressor (McClintock 
1978; Pardue et al. 2005). 
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TEs have become important players in dosage compensation of X-linked genes as well. In 
female Eutherian (placental) mammals that carry two X chromosomes, as opposed to an X and a Y  
chromosome, dosage compensation in achieved via random mosaic inactivation and 
heterochromatinization of one of the X chromosomes (Ogawa et al. 2008; Minajigi et al. 2015). The 
development of this system appears to correlate with acquisition of XIST and enrichment for  
LINE/L1 element density as Metatherian (marsupial) mammals do not carry the XIC responsible for 
producing XIST and their X chromosomes are actually less TE-dense than their autosomes. 
Metatherians in turn constitutively inactivate the paternal X chromosomes in females, which is 
currently believed to be the ancestral therian dosage compensation strategy (Mikkelsen et al. 2007). 
In the early Eutherian female embryo however, random transcription from the XIC results in the non-
coding XIST gene transcript coating one X-chromosome in cis, thus initiating silencing of most of the 
genes on the X chromosome. The high density of LINE elements present on the X chromosome are 
believed to aid in efficient spreading of heterochromatin away from the XIC (Figure 6E.1 and 6E.2), a 
theory supported by evidence that if the XIC is translocated to an autosome, the distal spread of 
heterochromatin is patently less efficient (Lyon 2006). It is possible that low recombination rates 
between the two sex chromosomes have resulted in the high density of LINE elements observed on 
the X chromosome, as the Y chromosome displays higher than average LINE density as well 
(Mikkelsen et al. 2007). 
II.2: TEs in Genome Regulation:  
 Understanding TE-host interactions in the pre-genomic era constituted investigation of 
individual elements, resulting in hand-curated lists of TEs that had acquired some type of cellular role 
– a process termed exaptation by Gould and Vrba in 1982 (Gould 1982; Lowe et al. 2007). And the 
number of different types of roles these elements have been described to fill is truly astounding: from 
providing distal enhancers (Bejerano et al. 2006; Santangelo et al. 2007) and alternative splice sites 
(Nekrutenko and Li 2001) to TF binding sites (Thornburg et al. 2006). Like shining a flashlight into a  
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dark room, this type of investigation began to shed some light on how truly versatile TEs have the 
capacity to be. The rise of the genomic era has since allowed scientists to observe a whole genome’s 
worth of information from various points along phylogenetic trees, and to begin to determine the 
extent of TE exaptation by uncovering TE-derived sequences that have become fixed under 
constrained functional selection over long periods of evolutionary time. Such investigations have 
proven that TEs can, and frequently are, utilized by the host, and the picture emerging from such 
investigations paints TEs as a driving force behind evolutionary innovation and speciation (Miller et 
al. 1999; Marino-Ramirez et al. 2005; Mikkelsen et al. 2007). 
On the one hand, TEs can provide pure coding sequence that may come to serve the host as 
novel genes. A particularly striking phenomenon that illustrates this point is that disparate 
mammalian species have co-opted Env proteins from different ERVs to serve convergent functions in 
placental development (Prudhomme et al. 2005; Dunlap et al. 2006). Furthermore, the genomes of 
many higher organisms contain large quantities of intronless “retrogenes;” pseudogenes which carry 
the hallmarks of arising via retrotransposition that by some estimates may constitute 25-50% of all 
active genes. Of particular note, the most abundant intronless genes in higher eukaryotes are 
potassium channel family and G protein-linked receptor family members, suggesting involvement of 
retrotransposition in the development of complexity and diversity in the vertebrate nervous system 
(Betran et al. 2002; Brosius 2003). Additionally, TEs can provide a platform for large-scale genomic 
duplications, deletions, and inversions during DNA replication due to their repetitive nature and the 
nature of transposition intermediates (Brosius 2003; Mikkelsen et al. 2007). Indeed, evolutionary 
patterns of acquired segmental duplications seem to exhibit intervals of relative quiescence 
punctuated by phases of heightened activity, similar to observed patterns of retrotransposition 
(Brosius 2003). This pattern has led some to speculate whether periods of active transposition may 
“regulate the global tempo of phenotypic change” (Rando and Verstrepen 2007). RTEs are also 
frequently found at the junctions of segmental duplications, as DNA repair processes are capable of 
capturing and inserting cDNA into DNA damage loci (Moore and Haber 1996; Teng et al. 1996).  
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FIGURE 7. Mechanisms by which TEs may exert control over endogenous gene expression. 
Possible mechanisms by which TEs can influence gene expression at the (A) transcriptional and (B) 
post-transcriptional level [adapted from: (Feschotte 2008)]. 
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Paralogues generated by segmental duplication provide a substrate for genic invention, as one copy is 
now liberated from functional constraint and free to acquire mutations and explore evolutionary 
space. Such duplicated genes appear to adhere to the “rapid gene birth and death model” (Consortium 
2004; Mikkelsen et al. 2007), either functionally diverging in response to positive selection or 
promptly disintegrating due to lack of evolutionary benefit. However, this is by far the least numerous 
class of exapted TEs. 
In 1969, Britten and Davidson first put forth their theory of gene network evolution in higher 
eukaryotes, which prominently featured McClintock’s “controlling elements” (McClintock 1950; 
Britten and Davidson 1969; Feschotte 2008). Specifically, they hypothesized that repetitive elements 
had the potential to distribute a regulatory cassette throughout the genome, thus causing an 
assemblage of genes to become coregulated (Britten and Davidson 1969; Britten and Davidson 1971; 
Lowe et al. 2007; Feschotte 2008). Indeed, evidence for such a relationship between a family of LTR 
RTEs and p53 master regulator binding sites has been uncovered (Wang et al. 2007). Other work has 
confirmed that TEs do in fact carry cis regulatory elements that are designed to interact with host 
trans factors, such as promoter and enhancer motifs, splicing and polyadenylation signals, and TF 
binding sites (Feschotte 2008; Batut et al. 2013).  Insertion of TEs can influence endogeneous gene 
expression at the transcriptional level by providing alternative promoters, physically disrupting a 
coding sequence, introducing a new cis regulatory element such as a novel TF binding site, inducing 
antisense transcription if inserted into an intron, or nucleating heterochromatin formation (Figure 7A). 
At the post-transcriptional level, TE insertion into coding sequence can introduce novel alternative 
polyadenylation signals, premature stop codons, miRNA target sites, alter splicing to result in either 
intron retention or exon skipping, or, in the case of TEs containing cryptic sites, result in exonization 
leading to potential new protein isoforms (Figure 7B). Documented examples exist for most of these 
various possibilities (Feschotte 2008). A substantial fraction of 5’ and 3’ UTRs appear to contain TE-
derived sequences (Jordan et al. 2003). However, the contribution of TEs to genome regulation need 
not necessarily be restricted to insertion into direct coding sequence. The complete genome sequence  
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of Caenorhabditis elegans has demonstrated that the majority of RTEs are located in close proximity 
to host genes, implying a regulatory role (Ganko et al. 2003), while a survey of RTEs in S pombe 
found a disproportional number of elements associated with pol II promoters (Bowen et al. 2003). In 
fact, almost 25% of all experimentally characterized human proximal promoter regions ≤500 bp 
upstream of the TSS contain TE-derived sequences, including empirically validated cis-regulatory 
elements (Jordan et al. 2003). 
The genomes of complex metazoans harbor vast expanses of CNCS that, particularly in 
vertebrates, serve to organize chromatin domains and regulate the expression of neighboring genes. 
As such, it has been hypothesized that evolution of these regulatory regions underlies the complex 
morphological diversity observed amongst vertebrates (King and Wilson 1975; Carroll 2005). 
Examining patterns of CNEs within such sequence that appear to be under purifying selection 
provides insight into what types of roles repetitive DNA may be co-opted to perform, even once it has 
devolved past our ability to detect its origin. Comparative genomic analyses between Eutherians have 
established that CNEs, not protein coding genes, constitute the majority of conserved sequence 
(Waterston et al. 2002; Gibbs et al. 2004; Consortium 2005; Lindblad-Toh et al. 2005). In 2007, 
Mikkelson et al. reported the compilation of the first high quality draft of a Metatherian genome, 
providing a unique, well positioned outgroup to complement ongoing investigations of mammalian 
genome evolution implementing comparative genomic approaches within the Eutherian lineage. The 
results of their analyses confirm that the majority of innovation has occurred in CNEs postdating the 
divergence of Eutheria and Metatheria, with novelties in protein coding genes being rather rare. 
Recognizable TE sequence was found to account for at least 16% of Eutherian-specific CNEs 
(Mikkelsen et al. 2007), demonstrating that TEs have had a much greater role in genomic innovation 
than previously documented. Due to difficulties associated with recognizing TE sequences older than 
~100-200 MYA (Waterston et al. 2002; Gentles et al. 2007), this is likely to be a considerable 
underestimate. Amazingly, 99% of all CNEs were found in both human and opossum, suggesting that 
they perform such basic functions that they cannot be lost (Mikkelsen et al. 2007). 
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FIGURE 8. Assimilation of TEs into eukaryotic genomes and their lineage-specific residence 
near developmental genes and genes involved in neuronal cell adhesion. 
(A) Lineage-specific CNEs near key developmental genes; densities of eutherian CNEs present (blue) 
or absent (red) in opossum, plotted on a 1-Megabase sliding window across human chromosome 3. 
Expanded view shows eutherian-specific CNEs (red), eutherian CNEs not overlapping with amniote 
CNEs (blue) and amniote-specific CNEs (purple) across a 500-kilobase gene desert surrounding the 
SOX2 TF gene [adapted from: (Mikkelsen et al. 2007)]. (B) Evolutionarily-accelerated CNSs 
disproportionally associated with neuronal cell adhesion genes in humans. CNSs neighboring genes 
with both Entrez Gene neuronal function and GO cell adhesion function annotations are observed 
significantly more frequently than expected, while genes only annotated with Entrez Gene neuronal 
function and no GO cell adhesion function or genes only annotated with GO cell adhesion function 
and no Entrez Gene neuronal function are not observed more frequently than expected [adapted from: 
(Prabhakar et al. 2006)]. [C] The Saltatory Replication model of TE integration into genomes. Each 
family originates in a sudden event at some time point in the past. Increasing divergence is displayed 
as the thermal stability of reassociated pairs of strands of DNA formed between members of each 
family (Centigrade), while time is represented in Millions of years [adapted from: (Britten and Kohne 
1968)]. 
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While TE sequences are noticeably absent in the regions immediately surrounding the TSS of 
genes (Polak and Domany 2006), likely due to disruptions in transcription machinery interactions 
being negatively selected against, a study by Lowe, Bejerano, and Haussler (2007) revealed a  
noticeable enrichment of TE-derived sequences in gene deserts 0.1-1.0 megabase from the nearest 
TSS. This study examined CNEs derived from characterized TEs in the human genome that have  
been under purifying selection since the last boreoeutherian ancestor – at least 100 MYA, or before 
the human-dog split – representing deep conservation in the Eutherian lineage. A preference for TE-
derived sequences residing closest to TF genes or genes involved in development was discovered, 
particularly those involved in cell adhesion and neural development (Lowe et al. 2007). These results 
have been echoed in several other studies (van de Lagemaat et al. 2003; Sandelin et al. 2004; 
Lindblad-Toh et al. 2005; Woolfe et al. 2005; Polak and Domany 2006; Thornburg et al. 2006; 
Mikkelsen et al. 2007), which additionally emphasize roles for such CNEs in regulating genes for 
axon guidance receptors and morphogens as well (Figure 8A). Indeed, Prabhakar et al. (2006) report 
that regions of accelerated evolution in CNEs are similarly enriched in basal lamina GO terms 
associated with neuronal cell adhesion in both human (Figure 8B) and chimpanzee, but that there is 
very little overlap between specific elements in the two lineages. The authors remark that this 
situation would likely result in different consequences for brain development and cognitive function 
(Prabhakar et al. 2006).  As experimental studies of CNEs positioned in such a manner have 
frequently revealed cis-regulatory functionality for neighboring developmental genes (Waterston et 
al. 2002; Nobrega et al. 2003; de la Calle-Mustienes et al. 2005; Woolfe et al. 2005; Bailey et al. 
2006; Pennacchio et al. 2006), it appears that TE-driven evolutionary innovation in these regions 
would provide the foundation for the observed morphological and neurological diversity within the 
vertebrate lineage, although it should be noted that enrichment for TEs near neuronal genes may be 
due to their generally larger gene and intron size. Curiously, correlations have been noted between 
mouse B1 and human Alu densities in corresponding upstream regions of orthologous genes (Polak 
and Domany 2006), suggesting conserved functions in the more recently diverged primate and rodent  
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lineages. Retrotransposition rates are significantly different between rodents and primates, accounting 
for 10% of the spontaneous mutation rate in mouse and only 0.2% in humans. However, LINE and 
SINE distributions are much more strongly correlated between orthologous mouse and human loci 
than their respective base composition (Deininger et al. 2003), suggesting that some type of 
synonymous pressures may be at play in both lineages (Deininger et al. 2003; Silva et al. 2003; Polak 
and Domany 2006).  
When a novel TE enters a genome, it is free to transpose in an unconstrained manner, as it is 
effectively unrecognizable to the small RNA-based surveillance machinery of the cell. Newly 
experienced elements do not display much preference in where they transpose to, as observed with 
engineered versions of Tc1/Mariner introduced into frogs and fish or human LINE elements 
introduced into mouse (Ivics et al. 1997; Miskey et al. 2003; An et al. 2006). It appears that these 
elements actually initiate their own silencing due to the haphazard quality of transposition, since 
elements both contain their own repetitive sequences and insert in various orientations in the genome 
without regard to nearby transcription signals, genic context, or antecedent TE presence. Regulation 
of these elements therefore capitalizes on their tendency to create defunct copies upon arrival (Jensen 
et al. 1999; Slotkin et al. 2005). Fragmented relics of more ancient TEs accumulate in regions of 
constitutive heterochromatin due to reduced levels of recombination and selective pressure. Such 
elements are likely to generate cues to silence their whole family in trans. This experimentally 
documented process is amazingly reminiscent of the “saltatory replication” model (Figure 8C) first 
hypothesized by Britten and Kohne in 1968 for repetitive DNA (Britten and Kohne 1968). In this 
light, mobile elements are prime candidates for generating interspecies variation. They are, in fact, 
largely responsible for differences in the non-coding regions of various inbred populations. 
Intriguingly, evidence for requisite retrotransposition during cellular proliferation and differentiation 
(Kuo et al. 1998; Mangiacasale et al. 2003; Lu et al. 2014) has been described, perhaps representing a 
fascinating case of ontogeny recapitulating phylogeny. 
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III. Functionalization of Transposable Elements to Interact with the 
Environment: 
 The work of the past few decades has established that TEs are functionally important for 
genomic regulation and evolution at the cellular level. However, work from the past few years has 
elaborated ways in which TEs may be implemented at the level of the organism. As described above,  
the structure of TEs confers them with uniquely interesting biology, consequently allowing them to 
solve uniquely interesting biological problems. Their repetitive and mobile nature, in conjunction 
with the cis regulatory elements and enzymes they encode, allows them build complexity into basic 
genomic architecture and regulation. This complexity-building capacity may have also become 
advantageous as the multi-cellular organism began to deploy its genetic information to sense, 
interpret, and respond to the environment. The two organ systems specifically charged with 
interacting with the external environment in this manner are the nervous system and the adaptive 
immune system. And indeed, it is now apparent that both systems make intensive use of TEs. In the 
case of the immune system, the well-characterized V(D)J recombination mechanism represents 
domesticated Class II transposition (Slotkin and Martienssen 2007) which serves the purpose of 
providing a near-endless supply of unique antibodies with which to respond to foreign antigen 
invasion.  
In the mammalian nervous system it is now known that the L1 RTE becomes active and 
mobilizes during specific phases of neurodevelopment and neuroproliferation (Muotri et al. 2005; 
Coufal et al. 2009; Muotri et al. 2010), resulting in well-documented somatic mosaicism of both 
neurons and, to a lesser extent, glia in the adult brain (Coufal et al. 2009; Baillie et al. 2011; Evrony 
et al. 2012; Perrat et al. 2013; Evrony et al. 2015; Upton et al. 2015). While the precise function of 
this regulated developmental process for the brain has yet to be revealed, the evolutionary 
conservation of this process suggests functional benefit. 
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It is not by chance that the immune and nervous systems display striking similarity, as they 
are charged with remarkably similar tasks. Both systems are involved in the “in situ response to 
experience” (Edelman 1993; Mattick and Mehler 2008) and as such they both face the cumbersome 
challenges of data interpretation, storage and retrieval. Both cell types display features of “memory;” 
in which the system must “recall” a previously experienced event and launch a physical response of 
the correct speed, magnitude, and duration. Both of these systems have the ability to process a 
colossal amount of information – the B- and T-cells of the immune system must respond to an 
unlimited supply of foreign antigens, while a single neuron may make up to thousands of synaptic  
connections (Habibi et al. 2009; Kioussis and Pachnis 2009). Indeed, the nervous and immune 
systems display an impressive number of similarities. From a developmental and morphological 
perspective, both cell types are capable of tracing precise, targeted trajectories in response to 
chemoattractive and repulsive cues given off either by cells located along their migratory path or at 
their final destination. In the case of neurons this type of behavior is usually restricted to 
development, while immune cells retain this behavior throughout the life of the organism. The two 
systems are both also capable of recognizing environmental cues and transmitting information to and 
from spatially distant parts of the body, via active and passive immune cell mobility on the one hand 
and axons and dendrites on the other (Habibi et al. 2009; Kioussis and Pachnis 2009). Additionally, 
both the immune and nervous systems use concerted physical contact of surface molecules to affect 
communication of information from one cell to another. While the term “synapse” was first coined to 
describe these structures between nerve cells (Shaw and Allen 2001; Dustin and Colman 2002), 
immunobiologists were likely acutely aware of the similarities when they co-opted the term to 
describe the information sharing platforms of communicating immune cells. The morphological 
similarities of immune and nervous cells have been observed for quite some time; when Paul 
Langerhans originally described antigen-presenting dendritic cells in the epidermis, he misconstrued 
them for cells of the nervous system (Clatworthy et al. 2008). The two systems share a similar 
supracellular organization as well, with concentrated nuclei responsible for specific processes  
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intermixed with a more salt-and-peppered interspersion of cell types. This organization has been 
hypothesized in both cases to give rise to a non-linear integrative functionality essential for the 
complex data management responsibilities of the two systems (Kioussis and Pachnis 2009). Finally, 
prominent roles for programmed cell death have been described in the development of both systems 
(Blaschke et al. 1998; Gao et al. 1998). 
While early descriptive studies noted many of the similarities detailed above, more recent 
work has uncovered a striking overlap in the molecular signatures of the nervous and immune 
systems as well, possibly reflecting employment of a common chemical language (Hirayama and 
Yagi 2006; Clatworthy et al. 2008; Habibi et al. 2009; Kerschensteiner et al. 2009; Kioussis and 
Pachnis 2009; McAfoose and Baune 2009). Cytokines were originally discovered in the immune 
system and described to effect development and cellular functionality therein, including cell 
trafficking responsibilities at various stages of the immune response. These molecules were later 
shown to be important during neurodevelopment, most notably signaling the transition from 
neurogenesis to gliogenesis (Miller and Gauthier 2007), and are also known to perform prominent 
roles in such complex cognitive processes as synaptic plasticity and neuromodulation (McAfoose and 
Baune 2009). It is interesting to note that many of the principal cell-surface receptors of the brain, 
which are critical for neuronal interactions that dictate migration, survival, axon guidance and 
synaptic targeting, are members of the immunoglobulin superfamily (Maness and Schachner 2007; 
Mattick and Mehler 2008; Habibi et al. 2009; Kioussis and Pachnis 2009), leading to hypotheses 
regarding application of similar somatic diversification strategies in the two systems (Hunkapiller et 
al. 1989; Chun et al. 1991). In more recent years, immune cells have been found to express 
neurotransmitters and their associated receptors, as well as neuropeptides, neurotrophins, and 
glycoproteins classically associated with the growth, guidance and synaptogenesis of neuronal axons 
(Kikutani and Kumanogoh 2003; Levite 2008; Selmeczy et al. 2008; Yu et al. 2008; Camacho-Arroyo 
et al. 2009). There appears to be a general concordance between molecules governing process 
formation, cell motility, and antigen uptake during immunological synapse formation and those  
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FIGURE 9. The TE origins of V(D)J recombination. 
(A) Immunoglobulin genes are composed of arrays of variable (V), diversity (D), and joining (J) 
regions and each segment is flanked with by an RSS that is analogous to the TIR of a DNA 
transposon. (B) Rag1 and Rag2, autonomous immobilized transposases from the Transcrib family of 
Class II TEs, recognize various combinations of RSS sequences in each B or T cell precursor and (C) 
excise the intervening sequencing. This process can be conceptualized as relating to non-autonomous 
‘cut-and-paste’ transposition. (D) As the RSS sequences that interact with RAG proteins are different 
in each cell individual immunoglobulin cells carry different coding potentials, resulting in production 
of novel antibody proteins [adapted from: (Slotkin and Martienssen 2007)]. 
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regulating neuronal growth and development (Clatworthy et al. 2008). As an example, an interesting 
study by Yu et al. published in 2008 demonstrated that BASP1 and Plexin B2, among other molecules 
involved in neurite outgrowth and guidance, can act as molecular markers for B-cells that will 
terminally differentiate in response to exposure to primed T-cells, as opposed to those B-cells that 
will abort after brief induction in response to T-independent type 2 antigens (Yu et al. 2008). Overall, 
it appears that more sophisticated and flexible neural storage and retrieval capacities, immunological 
responses, and physiological responses to the environment have been fueled by contemporaneous 
expansions of mechanisms involving genome regulation, somatic plasticity, and cell surface receptor 
families in the vertebrate lineage (Mattick 2010).  
Notably, the most characteristic and well-delineated genetic mechanism responsible for the 
immune system’s ability to respond to environmental stimuli is an exapted transposition mechanism 
(Slotkin and Martienssen 2007). V(D)J recombination allows B- and T-cells to generate a diverse set 
of antibodies in order to respond to various antigens. Immunoglobulin genes are comprised of arrays 
of variable (V), diversity (D), and joining (J) regions, with each segment being bordered by an RSS 
(Sen and Oltz 2006; Slotkin and Martienssen 2007) (Figure 9A). Rag1 and Rag2, the two enzymes 
that catalyze V(D)J recombination, are effectively immobilized, autonomous transposases derived 
from the Transcrib family of DNA elements (Kapitonov and Jurka 2005). As the functional and 
structural features of RSSs are highly reminiscent of the TIRs of DNA TEs, the process of Rag 
proteins recognizing RSSs (Figure 9B) and excising the intervening sequence (Figure 9C) is, in 
essence, non-autonomous Class II transposition (Kapitonov and Jurka 2005; Slotkin and Martienssen 
2007). The individual RSSs that interact with the Rag proteins are stochastic and distinct in each cell, 
generating unique rearrangements of V, D, and J segments that are later transcribed and translated 
into unique antibodies (Figure 9D). This process is both tissue and stage specific, as these loci are 
only recombined in specific cell types, in response to certain signals at precise stages of cellular 
development (Sen and Oltz 2006; Slotkin and Martienssen 2007). Non-domesticated transposons are 
also known to respond to environmental cues. The yeast Ty5 retrotransposon is known to alter its  
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target site specificity based on the phosphorylation state of its TD in response to nutrient availability 
(Dai et al. 2007). When nutrients are readily available the TD is unphosphorylated and can interact 
with the heterochromatin protein Sir4, effectively targeting transposition to gene-poor 
heterochromatic regions and reducing its mutagenic potential. In the stressed state, however, the TD 
becomes phosphorylated, disrupting Sir4 interaction and allowing Ty5 to mutagenize gene-rich, 
euchromatic regions (Dai et al. 2007).  
 A growing body of evidence suggests that the cells of the brain also implement regulated 
transposition during their development. Chun et al (1991) discovered that Rag1, but not Rag2, is 
expressed in the embryonic murine CNS in cell body-dense regions (Chun et al. 1991). Two other 
enzymes, XRCC4 and DNA ligase IV, are involved in DNA repair following Rag1 and Rag2 activity 
and are expressed in a variety of cell types. It has been reported that XRCC4 and DNA ligase IV 
deficiency in mice results in late embryonic lethality with massively defective lymphogenesis and 
neurogenesis. B- and T-cells of these mice arrest development around the progenitor stage where 
V(D)J recombination begins, while extensive apoptotic cell death occurs in the developing nervous 
system precisely temporally trailing a wave of neurogenesis (Gao et al. 1998). This remarkable 
phenotype hints at a susceptibility period at the point at which neuronal precursors transition to post-
mitotic neurons (Gao et al. 1998). Such an effect could conceivably be due to an inability to repair 
DSBs generated by active transposition events. It has also been noted that newly born neurons in rat 
embryonic cortex display the highest irradiation sensitivity (Gao et al. 1998), again hinting at a 
pronounced susceptibility to DSBs at this particular developmental stage in neurogenesis.  
While a diversity of human tissues express L1 processed transcripts and several different 
transformed human cell lines support its retrotransposition, a recent body of work has made use of an 
engineered GFP reporter derived from the element to demonstrate the prevalence of active 
retrotransposition during neurodevelopment (Muotri et al. 2005; Garcia-Perez et al. 2007b; Coufal et 
al. 2009; Kuwabara et al. 2009; Muotri et al. 2009; Muotri et al. 2010) (Figure 10A – 10B.2). The 
engineered L1 mobilizes in rat hippocampal neuronal stem cell-derived NPGs (Muotri et al. 2005)  
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FIGURE 10. Somatic L1 mobilization results in mosaicism in the adult mammalian brain. 
(A) Schematic representation of the L1-EGFP reporter cassette. EGFP has been inserted in the 3’ 
UTR of L1 in a reverse orientation and with an artificial intron embedded in the center of the 
sequence. Upon transcription the intron is removed, and produces full-length EGFP once the cassette 
has re-integrated back into the genome [adapted from: (Muotri et al. 2009)]. (B) Exposure to exercise 
(wheel running), which has previously been documented to enhance adult neurogenesis in the adult 
neuroproliferative zone of the dentate gyrus, results in dramatic elevation of L1 mobilization in 
transgenic mice carrying the L1-EGFP reporter cassette (B.2) over sedentary controls (B.1) [adapted 
from: (Muotri et al. 2009)]. (C) Individual human neurons and glial cells display mosaicism of L1 
genomic copy number, with cortical neurons and, to a lesser extent, hippocampal neurons showing an 
over-all higher genomic copy number than hippocampal glial cells [adapted from: (Upton et al. 
2015)]. 
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and in transgenic mice, resulting in somatic mosaicism in the adult mouse brain (Kuwabara et al. 
2009; Muotri et al. 2009). This process likewise appears to be both tissue and stage specific, as it is  
mediated by activation of the Wnt signaling pathway, which has various important roles in cell 
proliferation and migration, cell fate specification, and body axis patterning, and coordinated removal 
of Sox2, a TF critical for maintaining pleuripotency (Muotri et al. 2005; Kuwabara et al. 2009). L1 
activity can induce neural differentiation in vitro and has been experimentally validated to affect 
expression of neuronal genes near de novo insertion sites (Muotri et al. 2005). The fact that L1s have 
been experimentally demonstrated to function as bi-directional promoters suggests that they may 
indeed act to relay environmental signals to nearby endogenous genic loci (Kuwabara et al. 2009). 
This strategy is not restricted to embryogenesis, as wheel running in adult transgenic mice, which is 
known to induce adult neurogenesis, results in increased L1 retrotransposition in the adult 
neuroproliferative zone of the dentate gyrus (Muotri et al. 2009) (Figure 10B.1 and 10B.2).  
NPCs derived from human fetal brain are also capable of supporting retrotransposition and 
intra-individual brain regions display genomic copy number variations of L1 inserts, with the highest 
levels observed in the dentate gyrus, frontal cortex, and spinal cord, Importantly, this effect is not 
observed in other somatic tissues (Coufal et al. 2009). An elegant and rigorous study by Upton et al. 
(2015) combined single-cell sequencing and modified RC-seq, a methodology which implements 
sequence capture to enrich for sequences adjoining L1 TE ends, to determine average L1 somatic 
transposition rates in different cell types of the adult human brain. The authors determined that 
hippocampal neurons experience 13.7 somatic transposition events on average, while cortical neurons 
average 16.3 and glia experience 6.5 novel insertions on average per each individual cell (Upton et al. 
2015) (Figure 10C.1 – 10C.3). Both Baille et al. (2011) and Upton et al. (2015) have reported that the 
somatic transposition events from active TE families in humans - L1, Alu, and SVA - have a tendency 
to insert near protein coding genes that are active and differentially expressed in the brain and which 
are important for normal brain function (Baillie et al. 2011; Upton et al. 2015). While the open 
chromatin context of these genes may be responsible for the observed effect, it also enhances the  
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likelihood for functional relevance of these somatic TE insertion events and may allow mobile 
elements to preferentially target and modify brain-specific genes. It is possible that somatic TE 
mobilization during neurodevelopment could result in inter-individual variation, such as is observed 
in behavioral trait variation in isogenic mouse strains or even between monozygotic human twins 
(Singer et al. 2010). Such findings demonstrate that it is beyond feasible that the nervous system, just 
like the immune system, has co-opted TEs to perform critical, complex roles with regard to deploying 
genetic material to interact with the environment. 
 
IV. Do Transposable Elements Play a Role in Neurodegenerative Disease? 
 The interplay between TE activity and host response has provided the substrate for massive 
innovation in the evolution of the linear chromosome, dosage compensation of sex chromosomes, and 
regulation and employment of genomic information. Domesticated transposition endows the immune 
system with flexibility in responding to unpredictable invasion of foreign pathogens, and the 
phenomenon of L1 mobilization and somatic mosaicism in the brain similarly appears to be a cell 
type-specific and regulated process that in all likelihood endows the brain with some type of positive 
benefit or function. However, an accumulating body of literature suggests that general chromatin 
architecture begins to break down with age both in vitro and in studies of organismal aging, with a 
concomitant increase in TE expression (Wood et al. 2010; De Cecco et al. 2013b; Wood and Helfand 
2013). Indeed, TE activity has been documented to negatively impact lifespan and age-related 
senescence phenotypes in a wide-ranging collection of aging models (Driver and McKechnie 1992; St 
Laurent et al. 2010; Maxwell et al. 2011; Wang et al. 2011; De Cecco et al. 2013b), including recent 
work from the Dubnau lab that has shown that TEs of disparate families become de-suppressed and 
actively mobile in head tissue of wild type flies during normal organismal aging (Li et al. 2013). 
Furthermore work from our lab has shown that loss of function of Ago2, which is highly important 
for suppression of TEs in somatic tissue such as the brain in Drosophila, negatively impacts age- 
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related brain function as measured by a sensitive learning assay, implying that the consequent TE 
activity may play a role in age-related decline of neuronal function in normal aging (Li et al. 2013).
 It is interesting to note that derepression of TEs has been reported in a sundry assemblage of 
neurodegenerative diseases as well, including ALS, Rett syndrome, prion disease, macular 
degeneration, and FXTAS (Lathe and Harris 2009; Muotri et al. 2010; Greenwood et al. 2011; 
Kaneko et al. 2011; Li et al. 2012; Tan et al. 2012; Li et al. 2015). Activation of TEs has in fact been 
previously demonstrated to be causal for pathology in macular degeneration (Kaneko et al. 2011). As 
the type of TE activity described here represents age- or disease-related break down of general TE 
suppression mechanisms, as opposed to the regulated developmental process addressed above, the 
broad and general activation of many TE families described in these reports fulfills expectations 
(Lathe and Harris 2009; Li et al. 2012; Tan et al. 2012; Li et al. 2013). Of particular relevance to the 
current work, a recent study from the Dubnau and Hammell labs undertook to perform a meta-
analysis of publically available data sets from previously published papers regarding RNA 
sequencing studies of post-mortem tissue from patients with FTLD and cortical tissue from rodent 
models of TDP-43 pathology (Li et al. 2012). It was found that TDP-43 protein promiscuously binds 
TE-derived RNA transcripts and that TEs of a wide variety of families become de-suppressed in 
cortical tissue of rodent models of TDP-43 pathology. Moreover, it was demonstrated that in cortical 
tissue from human patients with FTLD, a disorder that frequently displays TDP-43 pathology in post-
mortem tissue, TDP-43 protein specifically looses its interaction with TE-derived RNA transcripts (Li 
et al. 2012). Such bioinformatic data, in combination with previous observations that impairing TE 
suppression mechanisms negatively impacts brain function (Li et al. 2013), suggest that TDP-43 may 
be having some type of role in suppressing TEs in normal brain tissue and that when this function is 
disrupted in the disease state the resultant TE activity may actually be having a causal effect in 
driving neurodegenerative phenotypes. It is the aim of my thesis work to mechanistically test this 
hypothesis using the genetic tools that are available in Drosophila. 
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CHAPTER 2 – Methods: 
 
Fly Stocks. 
All transgenic fly stocks used, with the exception of w(IR) and GMR-Gal4, were backcrossed into our 
in-house wild type strain, the Canton-S derivative w1118 (isoCJ1) (Tully et al. 1994), for at least five 
generations to homogenize genetic background. The GFP, OK107-, ELAV-, and Repo-Gal4 lines (Qin 
et al. 2012), as well as the hTDP-43 (Miguel et al. 2011), gypsy(IR) (Tan et al. 2012), and Repo-
LexA::GAD (Lai and Lee 2006) lines are as reported previously. The GMR-Gal4, Gal80ts, w(IR), 
GFP(IR), and tdTomato lines were acquired from the Bloomington Drosophila Stock Center (stock 
numbers: 43675, 7019, 25785, 9331, and 32221; respectively), and the loki(IR) line was acquired 
from the Vienna Drosophila Resource Center (stock number: v44980) (Dietzl et al. 2007). Flies were 
cultured on standard fly food at 22.5 °C. 
 
Bleach Treatment of Embryos. 
All fly stocks used for lifespan analysis and longitudinal qPCR experiments were double 
dechorionated by bleach treatment in order to remove exogenous viral infection (Li et al. 2013). 
Briefly, 4-hour embryos were collected and treated with 100% bleach for 30 min to remove the 
chorion. Treated embryos were washed and subsequently transferred to a virus-free room equipped 
with ultraviolet lights to maintain sterility. This was repeated for at least two successive generations 
and expanded fly stocks were tested via qPCR of whole flies to ensure DCV levels were below a 
threshold of 32 cycles.  
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Lifespan. 
Male flies were used for all lifespan assays since the majority of glial-expressing hTDP-43 flies that 
escape their pupal cases are male. Flies were housed 15 to a vial with a total of 75 flies per genotype 
and flipped every other day. All vials kept on their side in racks for the duration of the experiment.  
 
Locomotion behavioral assays. 
Locomotion behavior was assayed using the classic Benzer counter current apparatus as in Benzer, S, 
1967 (Benzer 1967), with the following modifications: freshly eclosed flies were transferred into 
glass bottles with food and a paper substrate and plugged with foam stoppers.  Flies were transferred 
to fresh bottles every 48 hours until they reached the appropriate age for locomotion assays.  The 
Benzer assay was conducted in a horizontal position to with a fluorescent light source to measure 
phototaxis. 
 
qPCR and TaqMan Probes. 
Tissue preparation, cDNA synthesis and qPCR were performed as previously described (Li et al. 
2013) using the Applied Biosystems StepOnePlus Real-Time PCR System. All TaqMan Gene 
Expression Assays were acquired from Applied Biosystems and used the FAM Reporter and MGB 
Quencher. The inventoried assays used were: Act5C (assay ID Dm02361909_s1), Dcr-2 (assay ID 
Dm01821537_g1), Ago2 (assay ID Dm01805433_g1), TARDBP (assay ID Hs00606522_m1), TBPH 
(assay ID Dm01820179_g1), and loki (assay ID Dm01811114_g1). All custom TaqMan probes were 
designed following the vendor’s custom assay design service manual and have the following assay 
IDs and probe sequences: gypsy ORF2 (assay ID AI5106V; probe: 5’–AAGCATTTGTGTTTGATT 
TC-3’), gypsy ORF3 (assay ID AID1UHW; probe: 5’-CTCTAGGATAGGCAATTAA-3’), and DCV 
(assay ID AIPAC3F; probe: 5′-TTGTCGACGCAATTCTT-3′). 
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Whole mount immunohistochemistry and GFP imaging. 
Dissection, fixation, immunolabelling, and confocal imaging acquisition were executed as previously 
described (Chen et al. 2008). The ENV primary antibody was used as described in Li, et al. 2013 
(Song et al. 1994; Li et al. 2013). For TUNEL staining, the In Situ Cell Death Detection Kit, TMR red 
(Roche, 12156792910) was used. The same dissection, fixation, and penetration and blocking 
protocol used for antibody staining was followed (Chen et al. 2008), at which point the brains were 
transferred to the reaction mix from the kit for 2 hours at 4 °C followed by 1 hour at 37 °C. Brains 
were then washed, mounted, and imaged as previously described (Chen et al. 2008). For TDP-43 
immunohistochemistry, the primary full length hTDP-43 antibody (Protein Tech, 10782-2-AP) was 
used at a 1:100 dilution, and the primary pSer409 phosphorylated hTDP-43 antibody (Sigma Aldrich, 
SAB4200223) was used at a 1:500 dilution separately in conjunction with a 1:200 dilution of an 
Alexa Fluor 488-conjugated secondary antibody (Thermo Fisher Scientific, A-11070). Repo co-
labeling was performed using a 1:200 dilution of primary antibody (Developmental Studies 
Hybridoma Bank, 8D12) and a 1:200 dilution of a Cy3-conjugated secondary antibody (Molecular 
Probes, A10521). DAPI co-staining was performed after a brief wash in 1x PBS immediately 
subsequent to secondary antibody staining using DAPI Dilactate (Thermo Fisher Scientific, D3571) 
as per manufacturer specifications. All brains co-stained with DAPI were imaged on a Zeiss LSM 780 
confocal microscope using a UV laser and the Zeiss ZEN microscope software package. 
 
GFP Quantification. 
The gain on the confocal microscope was set using the positive control (Repo > GFP or OK107 > 
GFP) and kept consistent across all subsequent brains imaged. The GFP signal of the median 10 
optical sections of the appropriate structures (either the full brain for Repo or both lobes of the calyx 
for OK107, respectively) was calculated using ImageJ software, as previously described 
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(McCloy et al. 2014). These ten values were then averaged, and this number used as a representation 
for each individual brain. 5-10 brains were analyzed per group. 
 
TUNEL-positive Nuclei Detection and Quantification. 
For TUNEL staining, the In Situ Cell Death Detection Kit, TMR red (Roche, 12156792910) was 
used. The same dissection, fixation, and penetration and blocking protocol used for antibody staining 
was followed (Chen et al. 2008), at which point the brains were transferred to the reaction mix from 
the kit for 2 hours at 4 °C followed by 1 hour at 37 °C. Brains were then washed, mounted, and 
imaged as previously described (Chen et al. 2008). For imaging, the gain on the confocal microscope 
was set using the positive control (Repo > hTDP-43) and kept consistent across all subsequent brains 
imaged. A projection image was generated using the middle 50 optical slices from the z-stack image 
of the whole brain. This projection image was then thresholded using the maximum entropy technique 
(See: (Sahoo PK 1988)) via the Fiji plug-in for ImageJ software, and the subsequent binary image 
was subjected to puncta quantification using ImageJ software. Puncta quantification was performed 
only for puncta greater than 3 pixels to reduce the likelihood of counting background signal. The total 
number of puncta counted was then used as a representation for the number of TUNEL-positive 
nuclei for each brain in subsequent statistical analysis. 7-12 brains were analyzed per group. 
 
Drosophila Eye Imaging. 
Flies of the appropriate age and genotype were placed at -70 °C for 25 minutes and then kept on ice 
until immediately prior to imaging. Imaging was performed using a Nikon SMZ1500 stereoscopic 
microscope, Nikon DS-Vi1 camera and Nikon Digital Sight camera system, and the Nikon NIS-
Elements BR3.2 64-bit imaging software package. The experiment was designed such that each group 
is balanced for the number of mini-white transgenes and heterozygous for genomic white+. 
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TEM. 
Drosophila heads were removed, the cuticle removed and the brains fixed overnight in 2% 
paraformaldehyde and 2% glutaraldehyde in 0.1 mol/L PBS. Samples were rinsed in distilled water 
and post-fixed for one hour in 1% Osmium tetroxide in 1.5% potassium ferrocyanide in distilled 
water. Next, the samples were dehydrated in a graded series of ethanol and the final 100% ethanol 
was replaced with a solution of absolute dry acetone (Electron Microscopy Sciences, Hatfield PA). 
The samples were then infiltrated with agitation for one hour in an equal mixture of acetone and 
Epon-Araldite resin, followed by infiltration with agitation overnight in 100% resin. Samples were 
transferred to embedding capsules with the posterior head facing towards the bottom of the capsule  
and the resin was polymerized overnight in a vented 60 °C oven. Thin sections were made from the 
mushroom body region and collected on Butvar coated 2mm x 1mm slot grids (EMS) and the sections 
were counterstained with lead citrate. Thin sections were imaged with a Hitachi H700 TEM and 
recorded on Kodak 4480 negatives that were scanned with an Epson V750 Pro Scanner at 2400 DPI.  
 
Cloning. 
The three hTDP-43 alleles (hTDP-43 WT, hTDP-43 G294A, and hTDP-43 M337V) were amplified 
from plasmids generated by the Zador laboratory (idp349, idp350, and idp351, respectively) using the 
following primers: Forward: 5’ – CTCGAGATGTCTGAATATATTCGGGTAAACGAAGATGAG 
AACGA – 3’ and Reverse: 5’ – TCTAGACTACATTCCCCAGCCAGAAGACTTAGAATCCATG 
CTTGAGCC – 3’. These PCR products were double digested with XhoI and XbaI and inserted into 
pJFRC19. Both the orientation of the insert (5’ Sequencing Primer: 5’ – AGCAACCAAGTAAATCA 
ACTGC – 3’ and 3’ Sequencing Primer: 5’ – GAAGGAAAGTCCTTGGGGTC – 3’) and the 
presence or absence of the appropriate point mutation (Internal Sequencing Primer: 5’ – GTGGAGA 
GGACTTGATCATTAAAGG – 3’) were confirmed by Sanger sequencing.  For the myr-eGFP WT, 
myr-eGFP W58X, and λN-dDD constructs, inserts were synthesized by IDT and double digested with  
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XhoI and XbaI. λN-hDD was isolated as an EcoRI fragment from the pPicZa backbone provided by 
Dr. Rosenthal (Montiel-Gonzalez et al. 2013). All four of these constructs were ligated into pUAST 
attB. The presence and orientation of the inserts were again confirmed by Sanger sequencing using 
standard CMV Forward and M13 Reverse primers, as was the presence or absence of the point 
mutation in the myr-eGFP constructs (Internal Sequencing Primer: 5’ – ACGTAAACGGCCACAAG 
TTCA – 3’). For the pU6-eGFP-X construct, sense (5’ – GTCGGGGCCAGGGCACGGGCAGCTTG 
CGGCCCTGAAAAAGGGCCTGGTGCAGATGAAC – 3’) and antisense (5’ – CTAGGTTCATCT 
GCACCAGGCCCTTTTTCAGGGCCGCAAGCTGCCCGTG CCCTGGCCC – 3’) oligos were 
synthesized with appropriate overhangs, phosphorylated and annealed, and then ligated into  
BbsI/XbaI digested pCFD3. Insertion was verified by Sanger sequencing (5’ Sequencing Primer:      
5’ – CTCAGCCAAGAGGCGAAAAG – 3’). Constructs were injected into recipient embryos and 
transformant lines were isolated by standard procedures (BestGene). 
 
Statistics. 
For qPCR data, the p-values of all data sets with only two groups were calculated using an unpaired t-
test. Where an effect of age for more than two time points within one genotype was determined, a 
one-way ANOVA was performed, and where multiple ages and genotypes are represented a two-way 
ANOVA was performed; the results are reported in the figure legends. All pairwise comparisons for 
qPCR reported in the figures were calculated using the Bonferroni method for correction for multiple 
comparisons. For both the locomotion data and the GFP quantification, p-values were reported using 
the Sheffé method; ANOVA results are reported in the figure legends. Survival analyses for the 
lifespan curves were performed using the Kaplan-Meier method, and the Log-rank and Gehan-
Breslow-Wilcoxon test were used to compare survival curves. All pairwise comparisons for lifespan 
curves were corrected using the Bonferroni method. 
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CHAPTER 3 – Activation of an endogenous retrovirus contributes to 
neurodegeneration in a Drosophila TDP-43 model of Amyotrophic Lateral 
Sclerosis. 
Krug, L., Chatterjee, N., Borges-Monroy, R., Hearn, S., Theodorou, D., and Dubnau, J. 
 
Functional abnormality of TDP-43, an aggregation-prone RNA binding protein, is commonly 
observed in a spectrum of neurodegenerative diseases that spans motor neuron deterioration and 
progressive paralysis in ALS to dementia and cognitive decline in FTLD (Ling et al. 2013). We have 
expressed hTDP-43 in Drosophila neurons and glia, a technique that recapitulates important aspects 
of cellular TDP-43 protein pathology in post-mortem patient tissue when implemented in a variety of 
model systems and induces progressive locomotor impairment and premature death (Gendron and 
Petrucelli 2011; Haidet-Phillips et al. 2011; Ling et al. 2013; Meyer et al. 2014; Casci and Pandey 
2015; Chen et al. 2015). Here we report that expressing hTDP-43 in both neurons and glia impairs 
siRNA silencing. The particularly aggressive effects we observe with hTDP-43 expression in glia 
correlate with early and severe loss of control of a specific RTE, the ERV gypsy. We deduce that 
gypsy causes degeneration specifically in these flies because we are able to rescue hTDP-43 toxicity 
by concomitantly blocking expression of this RTE in glia, but not in neurons. Moreover, we 
demonstrate that blocking expression of loki, the Drosophila ortholog of the Chk-2 DDR factor, 
completely abolishes the rampant apoptosis observed in the CNS of flies that express TDP-43 in glia. 
This result suggests that the majority of cellular toxicity induced by glial hTDP-43 expression is a 
result of Chk-2 signaling following DNA damage. RTE activity partially contributes to this DNA 
damage-induced apoptosis as gypsy knockdown partially alleviates the rampant apoptosis observed in 
the CNS of flies expressing hTDP-43 in glia. Finally, we demonstrate that DNA damage-mediated 
apoptosis is relevant to physiological decline when hTDP-43 is expressed in both neurons and glia, 
consistent with broader RTE-mediated effects in both cell types. Our findings build upon recent  
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reports that the human ERV HERV-K is activated in certain subtypes of ALS, and that over-
expression of HERV-K Env results in DNA damage, progressive paralysis, and loss of volume in the 
motor cortex of transgenic mice (Douville et al. 2011; Li et al. 2015). Furthermore, our findings 
suggest a novel mechanism in which RTE activity drives neurodegeneration in hTDP-43-mediated 
disease and potentially implicates RTEs in the etiology of other neurodegenerative disorders as well. 
 
 
ALS and FTLD are two incurable neurodegenerative disorders that exist on a 
symptomological spectrum and share both genetic underpinnings and pathophysiological hallmarks 
(Chen-Plotkin et al. 2010). ALS itself is a muscle wasting disease that presents as progressive 
paralysis due to death of motor neurons. A notable hallmark of ALS symptomology is its focality and 
spread; paralysis usually starts in a distal portion of the body such as a hand or a foot and spreads 
ipsi- and contralaterally such that the usual cause of death is respiratory failure (Ravits and La Spada 
2009) (Figure 11C). This characteristic progression suggests a central role for non-cell autonomous 
effects in perpetuating the disorder. The focality-and-spread mechanism is pronounced in ALS as it 
affects motor neurons, which are found throughout the body and in the motor cortex. However a 
similar pattern is observed in various other types of neurodegenerative diseases as well, albeit in more 
restricted areas of the central brain. While 90% of ALS cases and a large swath of FTLD cases are 
considered to be sporadic in the sense that they are not precipitated by a known genetic cause, 
functional abnormality of TDP-43 protein is observed in the vast majority of both familial and 
sporadic ALS cases (~98% of all ALS cases) and in ~40% of FTLD cases (Ling et al. 2013; Saberi et 
al. 2015). Both the mechanism that initiates the nucleation of TDP-43 protein pathology in otherwise 
genetically normal individuals and the mechanism by which cell death occurs is not understood 
(Chen-Plotkin et al. 2010). Additionally, TDP-43 protein pathology has been documented in the 
secondary pathology of post-mortem brain tissue from patients diagnosed with a wide array of other  
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FIGURE 11. The structure of hTDP-43 and its pathology. 
(A) The crystal structure of hTDP-43 demonstrates that it homodimerizes to bind single stranded 
RNA and DNA via its N-terminal RNA recognition motifs [adapted from: (Kuo et al. 2009)]. (B) 
Disease-causing mutations cluster within the C-terminal glycine rich domain of human TDP-43. (C) 
Focality and spread mechanism of ALS pathological prognosis; warmer colors in the heat map 
associated with regions of more intense deterioration [adapted from: (Ravits and La Spada 2009)]. 
(D) Cellular TDP-43 pathology in post-mortem spinal cord sections from an ALS patient. 
Arrowheads indicate cells displaying TDP-43 pathology, while other cells present in this section 
display normal TDP-43 localization. Nuclei are shown in blue; TDP-43 immunoreactivity is shown in 
brown [adapted from: (Neumann 2009)]. 
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neurodegenerative diseases, including hippocampal sclerosis, Alzheimer’s disease, corticobasal 
degeneration, and dementia with Lewy bodies (Amador-Ortiz et al. 2007; Wang et al. 2008).  
TDP-43 is a member of the hnRNP family and homodimerizes to bind single stranded RNA 
and DNA with UG/TG-rich motifs (Kuo et al. 1998) (Figure 11A). This pleiotropic protein was 
originally identified as a transcriptional repressor that binds to the TAR element of the HIV-1 
retrovirus to repress transcription (Ou et al. 1995), and has reported roles in transcriptional regulation, 
pre-mRNA splicing and mRNA transport, translational regulation, and miRNA biogenesis in the wild 
type state (Ayala et al. 2005; Kuo et al. 2009; Ling et al. 2013). TDP-43 is capable of shuttling back 
and forth from the nucleus to the cytoplasm but is predominantly found in the nucleus in healthy 
cells. In cells that are experiencing TDP-43 protein pathology, the protein accumulates in dense 
cytoplasmic inclusions that include full-length protein, caspase cleavage products and C-terminal 
fragments of TDP-43, as well as abnormally phosphorylated and ubiquitinated protein (Arai et al. 
2006; Wang et al. 2008; Neumann 2009) (Figure 11D). The vast majority of mutations in the 
TARDBP gene that encodes TDP-43 and which have been documented to cause human disease 
cluster within the C-terminal glycine rich domain (Figure 11B). Missense mutations here map to 
highly conserved residues (Pesiridis et al. 2009; Polymenidou and Cleveland 2011; Ling et al. 2013), 
suggesting that they are critical for TDP-43 function.  
Animal models in which human TDP-43 is transgenically over-expressed reproduce many of 
the signatures of human disease, including aggregation of TDP-43 protein in cytoplasmic inclusions 
and downstream neurological effects (Gendron and Petrucelli 2011; Ling et al. 2013; Casci and 
Pandey 2015).  Although such animal models are imperfect representations of what is largely a 
sporadically occurring disorder, they have enabled the delineation of myriad cellular roles for TDP-43 
(Janssens and Van Broeckhoven 2013; Ling et al. 2013). TDP-43 pathology in animal models is now 
understood to broadly disrupt RNA regulation, resulting in global dysfunction in mRNA stability and 
splicing, de-repression of cryptic splicing, and biogenesis of some microRNAs 
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(Chen-Plotkin et al. 2010; Gendron and Petrucelli 2011; Kawahara and Mieda-Sato 2012; Ling et al. 
2013; Casci and Pandey 2015; Ling et al. 2015). In principle, any of the cellular impacts of TDP-43 
protein pathology could contribute to disease progression either alone or in combination.  However, 
no clear consensus has yet emerged regarding the underlying causes of neurodegeneration.   
We advance the novel hypothesis that a morbid loss of control of RTEs contributes to the 
cumulative degeneration observed with TDP-43 pathology. This RTE hypothesis is founded on a 
series of observations. First, RTEs are expressed in somatic tissue (Garcia-Perez et al. 2007b; 
Kazazian 2011) and actively replicate during normal brain development, leading to de novo genomic 
insertions in adult brain tissue (Muotri et al. 2005; Coufal et al. 2009; Muotri et al. 2009; Baillie et al. 
2011; Evrony et al. 2012; Perrat et al. 2013; Evrony et al. 2015; Upton et al. 2015). Second, 
deterioration of RTE suppression – and resultant RTE activity – has been documented with advancing 
age in a variety of organisms and tissues (Maxwell et al. 2011; De Cecco et al. 2013a; Savva et al. 
2013; Zhu et al. 2014; Patterson et al. 2015), including the brain (Li et al. 2013). Moreover, 
expression of RTEs has been associated with a suite of neurodegenerative diseases (Lathe and Harris 
2009; Muotri et al. 2010; Douville et al. 2011; Greenwood et al. 2011; Kaneko et al. 2011; Li et al. 
2012; Tan et al. 2012; Li et al. 2015). Indeed, reverse transcriptase biochemical activity has been 
shown to be present in both serum and cerebrospinal fluid (CSF) of HIV-negative ALS patients 
(Steele et al. 2005; MacGowan et al. 2007; McCormick et al. 2008; Alfahad and Nath 2013), and a 
specific RTE, the human ERV HERV-K, is both expressed in post-mortem cortical tissue of ALS 
patients (Douville et al. 2011; Alfahad and Nath 2013; Li et al. 2015) and can cause motor neuron 
toxicity when its Envelope (ENV) protein is expressed in transgenic mice (Li et al. 2015). Finally, we 
have previously demonstrated via meta-analysis of RNA Immunoprecipitation (RIP) and Crosslinked 
RIP (CLIP) sequencing data that TDP-43 protein binds promiscuously to RTE–derived RNA 
transcripts in rodent and human brain tissue, and that this binding is selectively lost in cortical tissue 
of FTLD patients (Li et al. 2012). RTEs inherently act as genome destabilizers; their very nature is to 
replicate themselves, inducing DNA double strand breaks and inserting themselves into new genomic  
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locations in the process. Transposon-derived sequence constitutes ~40% of the human genome, a 
quantity which encompasses a surprisingly large number of functional RTE copies. Even the high 
levels of RTE RNA transcripts that accumulate when suppression is lost can be potentially cytotoxic, 
as observed with macular degeneration (Kaneko et al. 2011). The notion that TDP-43:RTE transcript 
interactions may be lost in the disease state (Li et al. 2012) is therefore particularly attractive when 
considered in the context of RTEs’ notorious destructive capacity, which has been extensively 
documented in many other biological contexts (O'Donnell and Boeke 2007; Malone and Hannon 
2009; Crichton et al. 2014).  
 
RESULTS 
gypsy ERV is induced in response to glial expression of hTDP-43 
In order to determine whether RTEs mediate TDP-43 pathological toxicity, we implemented 
an established animal model in which hTDP-43 is transgenically expressed in Drosophila.  As with 
other animal models, including mouse, rat, fish, and C elegans, such expression reproduces many 
neuropathological hallmarks of human disease, likely via interference with endogenous protein(s) 
function (Ash et al. 2010; Kabashi et al. 2010; Gendron and Petrucelli 2011; Vanden Broeck et al. 
2014; Casci and Pandey 2015).  To test the impact of expressing hTDP-43 on RTE protein or 
transcript abundance, we hand-selected as a candidate of interest the Drosophila RTE, gypsy.  We 
chose gypsy because we have previously documented this RTE to become aggressively active and 
mobile in brain tissue of wild type flies with advancing age (Li et al. 2013) and gypsy is an ERV with 
functional similarity to HERV-K, which is expressed in some ALS patients (Douville et al. 2011; Li 
et al. 2015).  In patient tissue, TDP-43 protein pathology is observed in both neurons and glial cells 
(Chen-Plotkin et al. 2010) and an emerging literature has implicated glial cell toxicity in ALS 
(Haidet-Phillips et al. 2011; Meyer et al. 2014; Chen et al. 2015).  Toxicity of TDP-43 in glia has 
similarly been documented in animal models, including in Drosophila  
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(Diaper et al. 2013; Estes et al. 2013; Tong et al. 2013; Romano et al. 2015). Disease symptoms 
nucleate at or after middle age in ALS and FTLD cases, with progressive degenerative effects. We 
therefore examined the effects of transgenic hTDP-43 expression in the neuronal versus glial 
compartments of the brain on gypsy, as well as the compounding effects of age on pathological 
prognosis.  
We began by performing quantitative RT-PCR (qPCR) for both ORF2 (Pol) and ORF3 
(ENV) of gypsy on head tissue of flies expressing either pan-neuronal (ELAV > hTDP-43) or pan-glial 
(Repo > hTDP-43) hTDP-43 at two relatively young ages (2-4 and 8-10 days post-eclosion). We 
found an early and dramatic increase in expression of both ORFs (Figures 12A and 12B) specifically 
in flies expressing hTDP-43 in glia.  In contrast, flies expressing neuronal hTDP-43 and genetic 
controls that do not express hTDP-43 (see also: Li et al., 2013 (Li et al. 2013)) experience a wave of 
gypsy expression at the population level that occurs much later in age (Figure 13A for ORF3; similar 
effects seen for ORF2, data not shown). Whole mount immunolabeling of brains using a monoclonal 
antibody directed against the gypsy ENV glycoprotein (Song et al. 1994; Li et al. 2013) likewise 
shows early (5-8 days post-eclosion) and acute accumulation of strongly immunoreactive puncta 
particularly in brains of flies expressing glial hTDP-43 (Figure 12C). These intense puncta are 
observed throughout the superficial regions, which contain the majority of cell somata, as well as in 
deeper neuropil (Figure 12C and data not shown) and persists into older ages.  In contrast, we do not 
observe neuronal hTDP-43 expression to elevate gypsy levels above that seen in wild type flies at any 
time point with either qPCR or immunolabeling (Figure 12C and 13A). Given that effects of glial 
hTDP-43 expression on gypsy ENV immunoreactivity were so robust in 5-8 day old animals, we 
examined ENV at earlier time points. We found that in animals expressing hTDP-43 in glia, gypsy 
ENV protein expression appears post-developmentally, with little expression at 0 days (immediately 
following eclosion) and detectable levels appearing at 3 days post-eclosion. Interestingly, such 
expression in 3-day old animals appears stochastic in both intensity and spatial location (Figure 13B).    
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FIGURE 12: Glial hTDP-43 expression results in early and dramatic de-suppression of the 
gypsy ERV. 
(A) Transcript levels of gypsy ORF2 (Pol) as detected by qPCR in whole head tissue of flies 
expressing hTDP-43 in neurons (ELAV > hTDP-43) versus glia (Repo > hTDP-43) at a young (2-4 
Day) or aged (8-10 Day) time point. Transcript levels normalized to Actin and displayed as fold 
change relative to flies carrying the hTDP-43 transgene with no Gal4 driver (hTDP-43 / +) at 2-4 
Days (means + SEM). A two-way ANOVA reveals a significant effect of genotype (p < 0.0001) but 
no effect of age (p = 0.5414). N = 8 for all groups. (B) An equivalent analysis shows that gypsy ORF3 
(Env) likewise displays a significant effect of genotype (p < 0.0001) and no effect of age (p = 
0.6530). N = 4 for the 2-4 Day cohort and N = 5 for the 8-10 Day cohort.  (C) Central projections of 
whole mount brains immunostained with a monoclonal antibody directed against gypsy ENV protein 
reveals dramatic, early accumulation of ENV immunoreactive puncta in brains expressing glial 
hTDP-43 (5-8 Days) in comparison to both age-matched genetic controls (ELAV / + ; Repo / + ; 
hTDP-43 / +) and flies expressing neuronal hTDP-43. This effect persists out to 19-25 Days post-
eclosion. ELAV / +, 5-8 Day (N= 3), 19-25 Day (N = 4); Repo / +, 5-8 Day (N = 3), 19-25 Day (N = 
3); hTDP-43 / +, 5-8 Day (N = 5), 19-25 Day (N = 2); ELAV > hTDP-43, 5-8 Day (N = 2), 19-25 Day 
(N =4); Repo > hTDP-43, 5-8 Day (N = 7), 19-25 Day (N = 8). 
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FIGURE 13: gypsy expression turns on stochastically in young brains and reaches peak 
expression in the population at mid-adulthood. Loss of suppression of gypsy cannot be explained 
by hTDP-43- or age-dependent effects on siRNA effector molecules. 
 (A) Transcript levels of gypsy ORF3 (Env) as detected by qPCR on whole head tissue of flies 
expressing (13.1) neuronal hTDP-43 (ELAV > hTDP-43), or genetic controls: (13.2) ELAV / + and 
(13.3) hTDP-43 / +. gypsy ORF3 transcript levels display an increase by 21-23 days post-eclosion 
that drops back down by 40-42 days post-eclosion, regardless of genotype. In all cases transcript 
levels have been normalized to Actin, and the aged cohort (8-10 days; 21-23 days; 40-42 days) are 
represented as a fold change over an appropriate young (2-4 day) cohort that has been processed in 
parallel. Unpaired t-tests have been used to calculate p-values for each aged cohort with its matched 
young cohort, while p-values comparing aged cohorts within genotypes have been calculated using 
the Bonferroni method for multiple comparisons. For all three genotypes a one-way ANOVA shows a 
significant effect of age on gypsy ORF3 transcript levels between the aged cohorts (ELAV > hTDP-
43, p < 0.0001; ELAV / +, p < 0.0001; hTDP-43 / +, p = 0.0346). N = 5 for all groups. (13.4) qPCR of 
whole head tissue reveals that the presence of the hTDP-43 transgene alone with no Gal4 driver 
results in elevation of gypsy ORF2 transcript levels. N = 6 for both groups. (B) Projections through 
whole-mount brains immunolabeled with a gypsy ENV monoclonal antibody demonstrate that gypsy 
expression turns on post-developmentally, with very little gypsy expression immediately following 
eclosion (0 Days) in genetic controls (hTDP-43 / + and Repo / +) and in flies expressing hTDP-43 in 
glia (Repo > hTDP-43). Expression turns on stochastically at 3 days post-eclosion only in the CNS of 
flies expressing glial hTDP-43. Replicates of 3-day old Repo > hTDP-43 brains illustrate the 
variability of gypsy expression at this early time point. N = 2 for all 0 Day groups; hTDP-43 / +, 3 
Day, N = 3; Repo / +, 3 Day, N = 4; Repo > hTDP-43, 3 Day, N = 7. (C) qPCR of whole head tissue 
demonstrates that reduced expression of (13.1) Dcr-2 and (13.2) Ago2 cannot account for loss of 
suppression of gypsy in flies expressing glial hTDP-43 (Repo > hTDP-43) at either 2-4 or 8-10 days 
post-eclosion. Transcript levels normalized to Actin and displayed as fold change relative to flies 
carrying the hTDP-43 transgene with no Gal4 driver (hTDP-43 / +) at 2-4 Days (means + SEM). For 
Dcr-2, a two-way ANOVA reveals an effect of age (p = 0.0006) but no effect of genotype (p = 
0.1081); for Ago2, a two-way ANOVA also reveals an effect of age (p = 0.0258) but no effect of 
genotype (p = 0.1591). N = 8 for all groups. (D) qPCR of whole head tissue demonstrates that age-
dependent changes in expression of Dcr-2 (top) and Ago2 (bottom) cannot account for age-
dependent loss of suppression of gypsy in flies expressing (13.1) neuronal hTDP-43 (ELAV > hTDP-
43) or genetic controls: (13.2) ELAV / + and (13.3) hTDP-43 / +. All data analyzed as in 13.1-13.3; 
one-way ANOVA shows an effect of age across almost all groups (ELAV > hTDP-43, Dcr-2, p < 
0.0001, Ago2, p = 0.0269; ELAV / +, Dcr-2, p < 0.0001, Ago2, p = 0.0051; hTDP-43 / +, Dcr-2, p < 
0.0001, Ago2, p = 0.3967). N = 8 for all groups.  
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siRNA-mediated silencing is disrupted by expression of hTDP-43 
These findings indicate that the machinery that normally stifles gypsy expression in young, 
healthy brain tissue is eroded by glial hTDP-43 expression. The major post-transcriptional RTE 
silencing system available in somatic tissue such as the brain is the small interfering RNA (siRNA) 
pathway (Lee et al. 2004; Aravin and Hannon 2008; Czech et al. 2008; Zhou et al. 2008; Ghildiyal 
and Zamore 2009; Saito and Siomi 2010). RTEs have been observed to produce siRNAs in many 
species (Vagin et al. 2006; Slotkin and Martienssen 2007; Ghildiyal and Zamore 2009), and RTE-
siRNA levels have been demonstrated to affect RTE activity (Lippman et al. 2003; Sijen and Plasterk 
2003; Yang and Kazazian 2006; Slotkin and Martienssen 2007). Moreover, disruptions in the siRNA 
pathway result in increased TE transcript levels (Svoboda et al. 2004; Czech et al. 2008; Li et al. 
2013) as well as novel insertions in the genome (Li et al. 2013; Xie et al. 2013). Indeed, we have 
previously shown that disruption of the major siRNA pathway effector Argonaute 2 (Ago2) leads to 
precocious gypsy expression in Drosophila head tissue and this is accompanied by rapid age-
dependent neurophysiological decline (Li et al. 2013). It is noteworthy that TDP-43 has been reported 
to co-localize with siRNA pathway components in both cell culture and human tissue (Peters and 
Meister 2007; Robb and Rana 2007; Pare et al. 2009; Freibaum et al. 2010; Liu-Yesucevitz et al. 
2010). And while disruption of TDP-43 has been shown to partially impair biogenesis of a subset of 
miRNAs in human cell culture (Kawahara and Mieda-Sato 2012), the effects of TDP-43 expression 
on the siRNA pathway are unknown. We therefore designed a genetic reporter system that would 
inform us as to whether hTDP-43 expression impairs the efficiency of Dicer-2 (DCR-2)/Ago2-
mediated siRNA silencing in the nervous system in vivo. 
Our reporter system relied on three components.  We co-expressed a Dcr-2 processed 
inverted repeat (IR) construct directed against GFP (GFP(IR)) with a GFP transgenic reporter.  By 
selecting an effective GFP(IR), we were able to generate substantial silencing of the GFP reporter 
(Figures 14A and 14B).  To test the effects of hTDP-43 on siRNA mediated silencing, we then co- 
	 123	
FIGURE 14: Glial and neuronal hTDP-43 expression erodes siRNA-mediated silencing. 
(A) Representative central projections show that co-expression of the hTDP-43 transgene, but not an 
unrelated tdTomato control transgene, interferes with the ability of a Dcr-2 processed inverted repeat 
(GFP(IR)) to silence a GFP transgenic reporter in glial cells using the Repo-GAL4 driver. 
Quantification of GFP signal for each group is shown in the appropriate bar graph; values are 
represented as relative fold change over Repo > GFP + GFP(IR) (mean + SEM). A two-way ANOVA 
reveals significant effects of both genotype (p < 0.0001) and age (p < 0.0001), and a significant age x 
genotype interaction (p < 0.0001). N = 5 for Repo > GFP and Repo > GFP + GFP(IR); N = 10 for all 
other groups. (B) An equivalent analysis demonstrates that hTDP-43 has a similar effect in the 
neuronal cells of the Drosophila mushroom body using the OK107-Gal4 driver, but with a later age 
of onset than hTDP-43 expression in glial cells. Quantification of GFP signal for each group is shown 
in the appropriate bar graph as in 2A. A two-way ANOVA reveals significant effects of genotype (p = 
0.0054) and age (p < 0.0001), as well as a significant age x genotype interaction (p = 0.0021). N = 5 
for OK107 > GFP and OK107 > GFP + GFP(IR); N = 10 for all other groups. C) Co-expression of 
hTDP-43, but not GFP, in the photoreceptor neurons of the fly eye under the GMR-Gal4 driver 
interrupts the ability of a Dcr-2 processed IR to silence the endogenous white+ pigment gene with an 
age of onset similar to that observed with neuronal expression of hTDP-43 in the CNS under OK107-
Gal4, resulting in characteristic clusters of red-pigmented ommatidia. N = 5 for GMR > w(IR) + 
Gal80ts OFF and GMR > w(IR) + Gal80ts ON; N = 20 for all other groups. 
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expressed our third component: either hTDP-43 or an unrelated control transgene (tdTomato).  This 
tripartite system was expressed either in all glial cells using the Repo-Gal4 driver (Figure 14A) or in 
neurons using the OK107-Gal4 driver, which provides high levels of expression in the well-defined 
and easily imaged population of central nervous system (CNS) neurons that constitute the mushroom 
body (Figure 14B). Brains of young (2-4 day) and middle aged (10-12 days) flies were imaged using 
confocal microscopy. In the case of neuronal expression we were able to carry the experiment out to 
old age (45-47 days), but this was not possible with glial expression of hTDP-43 as it results in 
dramatic reduction in lifespan (see below). What we observed was conspicuously reminiscent of 
hTDP-43’s impact on gypsy expression. Glial expression of hTDP-43 causes an early collapse of 
siRNA silencing, resulting in easily detectable expression of the GFP reporter. Such expression is 
significant even in 2-4 day old animals (Figure 14A).  GFP reporter expression is also seen at the 10-
12 day time-point, although these brains are obviously deteriorated (data not shown), which likely 
explains why GFP levels appear to drop off somewhat. Neuronal expression of hTDP-43 in the 
mushroom body has a similar but more progressive effect on siRNA-mediated silencing of our GFP 
reporter, with a later and more gradual onset (Figure 14B). Indeed, when we perform an analogous 
experiment using an endogenous reporter of siRNA mediated silencing in a separate structure we 
observe a similar effect. The GMR-Gal4 driver, which drives high levels of expression in the fly eye, 
was used to express an IR construct directed against the endogenous white+ pigment gene in place of 
GFP as a reporter (Figure 14C and Figure 15). As with mushroom body neurons in the CNS, 
expression of hTDP-43 in the eye causes a progressive de-repression of the silenced reporter. It is 
noteworthy that the erosion of siRNA efficacy observed in the eye manifests as clusters of red-
pigmented cells, a phenotype which is evocative of the stochastic clusters of ENV immunoreactivity 
observed early in response to glial hTDP-43 expression (Figure 14C). In contrast, simply turning on 
expression of white+ after development results in a uniform darkening of the eye with age (Figure 
15B). Taken together, these findings demonstrate that hTDP-43 expression disrupts siRNA-mediated 
silencing in several tissue types, resulting in robust de-silencing of reporter expression. In neurons  
	 127	
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FIGURE 15: Turning on white+ expression post-developmentally rescues red eye pigmentation 
in Drosophila. 
(A) Schematic representation of the experimental design. (B) Representative images demonstrating 
that turning off w(IR) expression post-developmentally rescues red pigmentation of the Fly eye. N = 5 
for all groups. 
  
1 Day Post-shift 24 Days Post-shift 92 Days Post-shift
Sh
ift
ed

U
ns
hi
ft
ed

GMR-GAL4
UAS-w(IR)
GAL80ts 
Development:
Hatching
3 Days
30 °C – GAL80ts off 30 °C – GAL80ts off
18 °C – GAL80ts on
a.
b.
	 129	
  
	 130	
hTDP-43 expression causes age-dependent progressive erosion of siRNA efficacy, while glial 
expression of hTDP-43 results in more precocious siRNA silencing impairment. In contrast, the gypsy 
ERV is only de-silenced when hTDP-43 is expressed in glia.  
 Although we have yet to identify which step of the siRNA pathway is disrupted by hTDP-43 
expression, it is not simply due to loss of expression of Dcr-2 or Ago2, the two major effectors of 
siRNA-mediated silencing in Drosophila (Lee et al. 2004; Czech et al. 2008; Zhou et al. 2008). qPCR 
of whole head tissue demonstrated that hTDP-43 expression in both neurons and glial cells does not 
affect absolute expression levels of Dcr-2 or Ago2 at either 2-4 or 8-10 days post-eclosion (Figure 
13C).  Thus down-regulation of these molecules is not responsible for the de-suppression of gypsy we 
observe with hTDP-43 expression in glia. In fact, in the case of genetic controls and flies expressing 
hTDP-43 in neurons, Dcr-2 and Ago2 levels actually increase with age beginning at 21-23 days post-
eclosion and persisting into old age (40-42 days old), suggesting that down-regulation of Dcr-2 and 
Ago2 likewise cannot explain the later elevation of gypsy expression observed in these genotypes 
(Figure 13D). 
 
Age-dependent neurological deterioration with neuronal versus glial hTDP-43 
expression 
 We next examined the relative impact of glial and neuronal hTDP-43 expression on the 
physiological health of the animal. As previously documented (Diaper et al. 2013; Estes et al. 2013; 
Romano et al. 2015), we see effects with both neuronal and glial expression. However, we observe 
differing severity and time courses that mirror the observed effects on siRNA-mediated silencing.  
Flies expressing hTDP-43 in neurons exhibit significant locomotor impairment at 1-5 days post-
eclosion, and flies expressing glial hTDP-43 show more severe locomotor impairment at this same 
age.  This effect is further exacerbated by 5-10 days post-eclosion; at which point the animals 
expressing hTDP-43 in glia are essentially immobile (Figure 16A). As previously reported 
	 131	
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FIGURE 16: Neuronal and glial hTDP-43 expression induces physiological impairment and 
toxicity with varying severity. 
(A) Flies expressing glial hTDP-43 display extreme locomotor impairment at 1-5 days post-eclosion 
in the Benzer fast phototaxis assay, while flies expressing neuronal hTDP-43 demonstrate a slight 
locomotor deficit in comparison to genetic controls (one-way ANOVA, p < 0.0001). This trend 
continues and is exacerbated by 5-10 days post-eclosion (one-way ANOVA, p < 0.0001). Four 
biological replicates performed for each experiment. (B) Lifespan analysis of flies expressing 
neuronal versus glial hTDP-43 in comparison to genetic controls. (C) Central projections of whole-
mount brains reveals a stark increase in TUNEL-positive cells in flies expressing glial hTDP-43 in 
comparison to genetic controls at 5 days post-eclosion. N = 16 for Repo / + and N = 18 for Repo > 
hTDP-43 (D) TEM likewise reveals rampant apoptosis in the neuropil of flies expressing glial hTDP-
43 at 12 days post-eclosion. Arrowheads indicate pro-apoptotic nuclei, as identified by morphology.   
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(Hanson et al. 2010; Li et al. 2010; Ritson et al. 2010; Estes et al. 2011; Miguel et al. 2011; Diaper et 
al. 2013; Estes et al. 2013), flies expressing neuronal hTDP-43 exhibit reduced lifespan in comparison 
to genetic controls.  But flies expressing hTDP-43 in glia display a more severely reduced lifespan 
with a median survival of only 6 days (Figure 16B). We further observe rampant apoptosis as 
detected by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) in the brains of 
flies expressing hTDP-43 in glia as early as 5 days post-eclosion (Figure 16C).  Similarly, we also 
observe profuse apoptosis in the neuropil of 12 day-old flies expressing glial TDP-43 by transmission 
electron microscopy (TEM; Figure 16D).  In contrast, driving expression of hTDP-43 in mushroom 
body neurons under OK107-Gal4 control results in little to no increase in apoptosis (consistent with a 
previous report (Li et al. 2010)) even when the flies were aged out to 30 days (Figure 17A). The 
relative expression of hTDP-43 under the two major Gal4 drivers we are using, Repo-Gal4 and 
ELAV-Gal4, does not differ with age, suggesting that divergent age effects on expression level cannot 
account for the observed differences in toxicity and impact on physical health (Figure 17D and 17E, 
respectively). Furthermore, we do not observe any effect of hTDP-43 expression on levels of the 
endogenous fly ortholog, TBPH, regardless of cell type of expression (Figure 17F).  Thus, the 
phenotypes that we observe are not caused by indirect effects on TBPH transcript abundance but 
instead derive from the hTDP-43 transgene itself.  As is true in other animal models and in human 
patients, we cannot readily distinguish whether the effects we observe are due to toxic gain of 
function, dominant interference with an endogenous protein, or some combination thereof.  
Importantly, however, we can detect a disease specific phosphorylated isoform of hTDP-43 (Figure 
17B) as well as cytoplasmic accumulation and nuclear clearance of the protein (Figure 17C), 
implying that the human protein is being processed in the CNS of the fly as it is thought to be in the 
disease state in human tissue. 
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FIGURE 17: Characterizing UAS-hTDP-43 expression. 
(A) TUNEL staining reveals very little apoptotic activity when hTDP-43 is expressed in the 
mushroom body under OK107-Gal4, even when the animals are aged to 30 days post-eclosion. 
Mushroom bodies marked by co-expression of GFP, shown in green; TUNEL staining shown in red. 
OK107 > GFP, 5 Day, N = 3; OK107 > GFP + hTDP-43, 5 Day, N = 5; OK107 > GFP, 30 Day, N = 
5; OK107 > GFP + hTDP-43, 30 Day, N = 4. (B) Full length human TDP-43 (green) can be detected 
by immunolabelling in the brains of flies expressing glial hTDP-43 under the Repo-Gal4 driver at 21-
23 days post-eclosion, and co-localizes with Repo (red) immunoreactivity (left). Repo / + (N = 4); 
Repo > hTDP-43 (N = 4). Immunoreactivity for a disease-specific phosphorylated isoform of the 
protein (pSer409) can also be readily detected and co-localizes with Repo (right). Repo / + (N = 7); 
Repo > hTDP-43 (N = 4). A 63x blow-up is shown in the pop-out.  (C) Both the full-length (left) and 
disease specific (right) isoforms of hTDP-43 (green) are mainly observed in the cytoplasm and 
vacate the nucleus (visualized by DAPI co-staining, shown in blue). Arrowheads indicate the hTDP-
43-filled cytoplasm of a cortical glial cell wrapped around several neuronal nuclei in the neuropil of 
flies expressing glial hTDP-43. For full-length hTDP-43 antibody, Repo / + (N = 6), Repo > hTDP-43 
(N = 13); for pSer409 phosphorylated hTDP-43 antibody, Repo / + (N = 4), Repo > hTDP-43 (N = 9). 
(D) qPCR of whole head tissue demonstrates that transcript levels of hTDP-43 diminishes under 
Repo-Gal4 from 2-4 days to 8-10 days. Transcript levels normalized to Actin and displayed as fold 
change relative to 2-4 day old flies (means + SEM). N = 6 for all groups. (E) A similar effect of age 
on hTDP-43 expression is observed in neurons under ELAV-Gal4, and continues to drop off by 40-42 
days post-eclosion. A one-way ANOVA shows a significant effect of age (p < 0.0001). N = 6 for all 
groups. (F) qPCR of whole head tissue demonstrates that expression of hTDP-43 does not effect 
levels of the Fly ortholog, TBPH, regardless of cell type of expression. Transcript levels normalized 
to Actin. N = 4 for the hTDP-43 / + group, N = 5 for all other groups. 
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Effects of hTDP-43 on lifespan and apoptosis are mediated by gypsy expression 
and Chk2 activity 
 We have delineated striking parallels between the age of onset and severity of effects of glial 
versus neuronal hTDP-43 expression on gypsy expression on the one hand and on physiological 
impairment and apoptosis on the other. These correlative observations, along with the extensively 
documented toxic effects of loss of control of RTEs (O'Donnell and Boeke 2007; Malone and Hannon 
2009; Li et al. 2013; Crichton et al. 2014), suggest that loss of control of gypsy might in fact account 
for the physiological toxicity observed with hTDP-43 expression in glia. To test whether the 
Drosophila ERV gypsy causally contributes to the toxic effects of hTDP-43, we used a previously 
published IR construct (Tan et al. 2012) directed against gypsy ORF2 (gypsy(IR)) that is sufficient to 
reduce the expression of gypsy by approximately 50% in head tissue of 28-day old animals (Figure 
18A). We found that co-expression of this gypsy(IR) robustly suppresses the extreme lifespan deficit 
we observe in flies expressing glial hTDP-43 (Figure 18B), an effect which is not observed with a 
control IR construct (GFP(IR); Figure 18C). Therefore, the expression of gypsy caused by hTDP-43 
expression in glia is responsible for a significant portion of the toxicity that leads to drastically 
premature death in these animals. Consistent with our observations that neuronal expression of hTDP-
43 does not elevate gypsy expression above wild type levels at any given time point over the course of 
lifespan, co-expression of gypsy(IR) likewise does not suppress the lifespan deficit exhibited by 
animals expressing hTDP-43 in neurons (Figure 18D). As gypsy(IR) yields only a partial reduction in 
gypsy expression levels (Figure 18A), we cannot rule out the possibility that gypsy also contributes to 
neuronal toxicity of hTDP-43 below the threshold of the ability of this IR to knock down. However, 
the glial specificity of gypsy(IR) lifespan rescue is consistent with our observation that gypsy itself is 
precociously and aggressively de-silenced strictly in the brains of animals expressing hTDP-43 in 
glial cells.  
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FIGURE 18: gypsy ERV expression and DNA damage both contribute hTDP-43 mediated 
toxicity. 
(A) qPCR on head tissue demonstrates that expressing an IR directed against gypsy ORF2 (gypsy(IR)) 
in neurons (ELAV > gypsy(IR)) or glia (Repo > gypsy(IR)) effectively inhibits age-dependent 
elevation of gypsy transcript levels, and results in an ~2.5-fold reduction at 28 days post-eclosion. 
gypsy transcript levels normalized to Actin and displayed as fold change relative to flies carrying the 
gypsy(IR) with no Gal4 driver (gypsy(IR) / + ; displayed as means + SEM). A one-way ANOVA 
shows a significant effect of genotype (p = 0.0182). N = 2-3 biological replicates generated from 
heads of 5 mL of flies for each group. (B) Lifespan analysis shows that co-expression of gypsy(IR) 
partially rescues the lifespan deficit exhibited by flies expressing glial hTDP-43. (C) Co-expression 
of an unrelated GFP(IR) control does not effect the lifespan of flies expressing glial hTDP-43. (D) 
Co-expression of gypsy(IR) has no effect on lifespan in flies expressing neuronal hTDP-43. (E) An 
equivalent analysis as described for 4A demonstrates that neuronal (ELAV > loki(IR)) and glial    
(Repo > loki(IR)) expression of an IR directed against loki (loki(IR)) effectively blocks the age-
dependent elevation of loki transcript levels, resulting in an ~2-fold reduction at 28 days post-
eclosion. A one-way ANOVA shows a significant effect of genotype (p = 0.0039). N = 3-4 biological 
replicates as in 4A. (F) Lifespan analysis shows that co-expression of loki(IR) fully rescues the 
lifespan deficit exhibited by flies expressing glial hTDP-43. (G) Co-expression of loki(IR) likewise 
fully rescues the lifespan deficit exhibited by flies expressing neuronal hTDP-43. (H) Central 
projections of whole-mount TUNEL stained brains reveal a noticeable reduction in the apoptotic 
activity induced by glial hTDP-43 expression (Repo > hTDP-43 + GFP(IR)) when gypsy expression is 
knocked down (Repo > hTDP-43 + gypsy(IR)), while knocking down loki completely alleviates the 
apoptosis induced by glial hTDP-43 expression (Repo > hTDP-43 + loki(IR)). (I) Quantification of 
(H), normalized to the positive control (Repo > hTDP-43 + GFP(IR)). N = 12 for Repo / +; N = 9 for 
Repo > hTDP-43 + GFP(IR); N = 7 for Repo > hTDP-43 + gypsy(IR); and N = 7 for Repo > hTDP-43 
+ loki(IR).  
*All of the lifespans in Figure 18 and Figure 19 were performed concurrently in order to ensure 
comparability across groups. Therefore, appropriate controls are shared across panels. 
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While the effects we observe on gypsy expression appear to be specific to hTDP-43 
expression in glia, our siRNA reporter assay has revealed that both neuronal and glial expression of 
hTDP-43 is sufficient to impair Dcr-2/Ago2-mediated silencing. General impairment of siRNA-
mediated silencing would be expected to affect RTE expression more broadly, and while the time 
course of deterioration of siRNA silencing is arguably more gradual in the neuronal subtypes assayed 
than in glial cells, it is significant and robust (Figures 14B and 14C). This finding is in agreement 
with our previous observations that TDP-43 protein normally exhibits widespread interactions with 
RTE transcripts in rodent and human cortical tissue and that these interactions are selectively lost in 
cortical tissue of FTLD patients (Li et al. 2012), as well as a recent report that knocking out the C 
elegans ortholog of hTDP-43 results in broad accumulation of transposon-derived RNA transcripts 
(Saldi et al. 2014). It is also compatible with our findings herein that both glial and neuronal hTDP-43 
expression in Drosophila induces significant negative impacts on physiological health, consistent 
with previous reports in this model system (Hanson et al. 2010; Li et al. 2010; Ritson et al. 2010; 
Estes et al. 2011; Miguel et al. 2011; Diaper et al. 2013; Estes et al. 2013). We therefore wondered 
whether gypsy(IR), with its demonstrable glia-specific effects, might neglect to detect the 
contributions of more widespread RTE activity that is likely to be induced by the general loss of 
siRNA-mediated silencing exhibited by both neurons and glia expressing hTDP-43. To generate an 
assay that could inform us of more general RTE activity in response to hTDP-43 expression, we 
capitalized on the previously documented ability of mutations in the ATR/Chk2 DNA damage 
response pathway to mask the toxic effects of accumulated RTE-induced DNA damage (Chen et al. 
2007; Klattenhoff et al. 2007). When DNA damage accumulates above a threshold at which point 
repairing the damage is no longer metabolically feasible, cells require ATR/Chk2 signaling to commit 
to apoptotic cell death. Thus mutations in Chk2 do not prevent accumulation of DNA damage; rather 
they prevent the signaling required for the cell to recognize that DNA damage has occurred and 
respond by committing to programmed cell death (Brodsky et al. 2004). We therefore employed an IR 
construct directed against loki (loki(IR)), the Drosophila ortholog of chk2, which is sufficient to  
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significantly reduce levels of endogenous loki mRNA (Figure 18E). Remarkably, co-expression of 
loki(IR) with hTDP-43 is able to fully rescue the lifespan deficit caused by hTDP-43 expression either 
in glia (Figure 18F) or in neurons (Figure 18G). This effect is not seen with a control IR construct 
(GFP(IR); Figure 18C).  Neither the gypsy(IR), GFP(IR), or loki(IR) constructs, when expressed 
individually under Repo-Gal4 (Figure 19A) or ELAV-Gal4 (Figure 19B) or present without a Gal4 
driver (Figure 19C), has such an effect on lifespan. This finding therefore supports the conclusion that 
Loki/Chk-2 activity, occurring concomitantly with loss of siRNA silencing, makes a major 
contribution to the pathological toxicity we observe with both glial and neuronal hTDP-43 
expression.   
The brains of flies expressing hTDP-43 in glia display rampant apoptosis, seen both with 
TUNEL staining (Figure 16C) and at the level of TEM (Figure 16D). This is in keeping with the 
current consensus that cells experiencing TDP-43 pathology in patient tissue die predominantly via 
apoptosis (Vanden Broeck et al. 2014). It appears that the decision of cells to commit to apoptosis in 
response to hTDP-43 expression is principally mediated by Loki, as co-expression of the loki(IR) 
which was so effective in suppressing hTDP-43 toxicity in survival analyses also abolishes the 
dramatic apoptosis observed in the CNS of flies expressing hTDP-43 in glia when these flies are aged 
to a time point which we have previously documented to display both dramatic gypsy expression and 
apoptosis (5-7 days; Figures 18H and 18I). This effect appears to be specific to loki(IR) as co-
expression of an unrelated UAS-(IR) construct (Repo > hTDP-43 + GFP(IR)) with hTDP-43 in glia 
does not significantly alter the number of TUNEL positive cells compared to brains of flies 
expressing hTDP-43 alone under Repo-Gal4 (Figure 19D). Based on what we know about the cell 
biological role of Loki/Chk-2, this finding is consistent with the conclusion that the cell death induced 
by hTDP-43 expression is mediated largely by Loki activity in response to hTDP-43-induced DNA 
damage. RTE activity does appear to contribute at least in part to the decision of cells to undergo 
apoptosis in response to hTDP-43 expression in glia, as knocking down gypsy partially alleviates the 
rampant apoptosis observed in the CNS of these animals (Figure 18H and 18I). Importantly, co- 
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FIGURE 19: Expression of IR constructs individually does not affect lifespan or hTDP-43 
expression. 
(A) Expression of gypsy(IR), loki(IR), and GFP(IR) individually in glial cells under the Repo-Gal4 
driver does not significantly alter lifespan. (B) Expression of gypsy(IR) and loki(IR) individually in 
neurons under the ELAV-Gal4 driver does not significantly alter lifespan. (C) The presence of each of 
the IR constructs alone without any Gal4 driver only moderately effects lifespan. (D) Co-expression 
of GFP(IR) with hTDP-43 under Repo-Gal4 does not significantly alter the number of TUNEL-
positive nuclei detected compared to hTDP-43 expression alone under Repo-Gal4. N = 8 for Repo > 
hTDP-43 and N = 9 for Repo > hTDP-43 + GFP(IR); data normalized to Repo > hTDP-43. (E) qPCR 
for hTDP-43 expression (TARDBP) on whole head tissue demonstrates that co-expression of each of 
the IR constructs with hTDP-43 under Repo-Gal4 (Repo > hTDP-43 + GFP(IR), Repo > hTDP-43 + 
gypsy(IR), and Repo > hTDP-43 + loki(IR), respectively) does not significantly reduce hTDP-43 
expression levels compared to hTDP-43 expression alone under Repo-Gal4 (Repo > hTDP-43) Fold 
change is displayed as the mean fold change relative to Repo > hTDP-43, while p-value represents the 
p-value of a two-tailed Student’s t-test in comparison to Repo > hTDP-43. N = 4 for all groups. 
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expression of the GFP(IR), loki(IR), and gypsy(IR) constructs used in both the TUNEL staining and 
survival analysis with hTDP-43 under Repo-Gal4 does not significantly reduce the expression of 
hTDP-43 (TARDBP) in whole head tissue, suggesting that reduced expression of hTDP-43 cannot 
account for the phenotypic rescue induced by loki(IR) or gypsy(IR) in either of these assays (Figure 
19E). This set of observations is in agreement with the well-documented accumulation of DNA 
double strand breaks induced by unleashing RTEs (Belgnaoui et al. 2006), as well as reports that 
transgenic expression of the HERV-K ENV protein in mice results in loss of volume in the motor 
cortex and DNA damage (Li et al. 2015). Our previous findings regarding hTDP-43’s broad 
interactions with RTE-derived RNA transcripts tempts us to postulate that the Chk-2-mediated 
apoptosis we observe in response to hTDP-43 expression in Drosophila glia is due to more general 
run-away activation of RTEs above and beyond the effects we have documented of hTDP-43 
expression on gypsy. However, while it is evocative that gypsy expression appears to contribute at 
least in part to the decision of cells to commit apoptosis in response to glial expression of hTDP-43, 
these results also do not rule out other effects of hTDP-43 expression on DNA damage recognition 
and repair. These findings lead to a model in which TDP-43 protein pathology in human cells results 
in a dramatic deterioration of siRNA-mediated silencing accompanied by activation of RTE 
expression. In this model cells that experience TDP-43 pathology commit to apoptosis via Loki/Chk-
2 activity that is the result of accumulation of hTDP-43-induced DNA damage. The DNA damage 
incurred by hTDP-43 pathology is likely to be caused at least in part by TDP-43’s effects on RTE 
activity. 
 
DISCUSSION 
We previously reported bioinformatic evidence for a physical link between TDP-43 protein 
and RTE RNAs in rodents and in human tissue (Li et al. 2012). Here we provide mechanistic 
evidence that TDP-43 pathology in flies is associated with a collapse of the siRNA-mediated  
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silencing system.  While we do not know the mechanism by which TDP-43 impacts siRNA silencing, 
it may involve direct interactions between TDP-43 and the RNAi protein machinery (Kawahara and 
Mieda-Sato 2012) and our previous findings suggest direct interaction with RTE RNAs (Li et al. 
2012).  We also demonstrate that the loss of siRNA silencing is accompanied by toxic expression of 
the gypsy ERV.  This finding is parsimonious with reports of high levels of reverse transcriptase 
activity in blood serum and CSF of HIV-negative ALS patients (Steele et al. 2005; MacGowan et al. 
2007; McCormick et al. 2008), accumulation of transcripts and protein from HERV-K, a human ERV 
of the gypsy family, in the CNS of ALS patients (Douville et al. ; Li et al.), and severe accumulation 
of virus-like inclusions detected by electron microscopy in both neurons and glia of the frontal cortex 
of one ALS patient with extended prolongation of life via artificial lung ventilation (Popova and 
Sakharova 1982). However, while overexpression of just the ENV protein of HERV-K has been 
demonstrated to induce progressive motor dysfunction in transgenic mice (Li et al. 2015), this is the 
first time that the induction of an endogenous RTE has been demonstrated to causally contribute to 
physiological deterioration in a model of human TDP-43 pathology. Our finding that the siRNA 
silencing system is compromised by hTDP-43 expression suggests the possibility that other classes of 
retrotransposons may be similarly activated. In the context of the Drosophila model, we provide 
strong evidence that hTDP-43-induced expression of gypsy contributes to DNA damage mediated 
apoptosis and plays a causal role in the physiological consequences for the animal. Our finding that 
Chk-2 activity is largely responsible for apoptosis in response to hTDP-43 expression suggests that 
gypsy may be successfully or abortively transposing into genomic DNA, however we are mindful of 
the fact that increased levels of gypsy proteins and RNAs may themselves be cytotoxic, as is observed 
with Alu elements in macular degeneration (Kaneko et al. 2011). These findings lead us to posit the 
“retrotransposon storm” hypothesis of neurodegeneration. We envision that loss of control of RTE 
expression and replication leads to a feed-forward mechanism, resulting in massive levels of activity 
that contribute to toxicity and degeneration in the nervous system. Our findings emphasize the 
importance of investigating a broader role of RTEs in TDP-43-mediated pathogenesis, and may  
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indicate a promising common avenue for novel therapeutic targets in both familial and sporadic cases 
of ALS. 
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CHAPTER 4 – Tool Development: 
Krug, L. and Dubnau, J. 
 
 In this section I will briefly describe tools and sample sets I have generated that will enable 
continued investigation of how TDP-43 pathology affects TEs in the CNS. While performing all the 
experiments I would like with these tools is beyond the scope of my thesis, they represent a 
significant portion of my effort during my time in the Dubnau lab and also reflect the ways in which I 
have been thinking about the phenomenology and the types of follow-up questions I believe will be 
important to address in the near future. Below I will outline the structure of these tools, the extent to 
which they have been validated or utilized, and what types of questions they may prove useful in 
addressing. 
 
I. LexAop-hTDP-43: 
Reasoning and Design:  
The LexAop system is a secondary yeast operator system that has been modified for use in 
Drosophila (del Valle Rodriguez et al. 2012) (Figure 20A). This system functions very much like the 
more ubiquitously utilized GAL4-UAS system but will not cross-react with the GAL4-UAS system if 
employed in the same animal because the two yeast operator proteins are expressed under separate 
endogenous promoters. Therefore, combined use of the LexAop and GAL4 systems in the same 
animal allows for cell type-specific expression of different transgenic constructs in two separate cell 
types (del Valle Rodriguez et al. 2012). Given the well-documented glial toxicity of TDP-43 and 
other ALS models (Haidet-Phillips et al. 2011; Diaper et al. 2013; Estes et al. 2013; Tong et al. 2013; 
Meyer et al. 2014; Chen et al. 2015; Romano et al. 2015), as well as the dramatic effects of glial 
hTDP-43 expression I have presented in Chapter II, the ability to express TDP-43 in glial cells while 
simultaneously monitoring effects on transgenic reporters in neurons in vivo would be highly  
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FIGURE 20. Generating LexAop-hTDP-43 transgenic fly lines. 
(A) Schematic representation of the LexA system in Drosophila melanogaster. (B) PCR 
amplification strategy for hTDP-43 WT, hTDP-43 G294A, and hTDP-43 M337V from plasmid 
constructs. (C) Cloning of hTDP-43 inserts into pJFRC19. 
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advantageous. I have therefore subcloned three alleles of hTDP-43 into a vector that will place them 
under LexAop control (Figure 20B and 20C). These three alleles include a wild type allele and two C-
terminal point mutant alleles that are known to cause human disease and which have been studied in 
other laboratory contexts (LexAop-hTDP-43 WT, LexAop-hTDP-43 G294A, and LexAop-hTDP-43 
M337V). I have generated transgenic fly lines from the LexAop-hTDP-43 WT construct, outcrossed 
the insertion to our wild type fly line, and validated its expression under Repo-LexA by qPCR. 
 
Validation:  
Subcloning of all three hTDP-43 alleles was validated by Sanger sequencing, and the LexAop-hTDP-
43 WT allele was sent out for injection into Drosophila embryos according to standard protocol. 
Transformants were validated by PCR of genomic DNA. I outcrossed two of these transformant lines 
to our in-house wild type strain for 5 generations to homogenize genetic background. I then either 
crossed these two lines to wild type flies or outcrossed flies carrying a Repo-LexA construct (Lai and 
Lee 2006). I performed qPCR on 2-4 day old head tissue of these groups to confirm whether the 
presence of Repo-LexA induced expression of LexAop-hTDP-43 WT in these two lines above 
background levels. Indeed, expression is elevated ~4-fold over background (Figure 21A and 21B). 
This is much less than is observed with glial expression of UAS-hTDP-43 under Repo-GAL4, which 
elevates TDP-43 expression ~20-fold over background at the same time point. However, it is on par 
with the expression levels I observe with UAS-hTDP-43 under ELAV-GAL4 in whole head tissue 
(~3.5-fold elevation over background), and likely reflects higher TDP-43 expression per cell than in 
the ELAV-GAL4 flies as there are orders of magnitude fewer glial cells than neurons in the whole fly 
brain. This feature may actually prove advantageous for future experiments as the Repo-GAL4 
phenotype is so severe that it makes collecting tissue extremely cumbersome. 
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FIGURE 21. Validating LexAop-hTDP-43 expression under Repo-LexA::GAD. 
(A) qPCR validation of expression of the transgenic LexAop-hTDP-43 WT Line A under Repo-
LexA::GAD in 2-4 day old Drosophila head tissue. (B) qPCR validation of expression of the 
transgenic LexAop-hTDP-43 WT Line B under Repo-LexA::GAD in 2-4 day old Drosophila head 
tissue. Values for Repo-LexA::GAD groups normalized to those for the appropriate control group 
(i.e.: Repo-LexA::GAD > LexAop-hTDP-43 A to LexAop-hTDP-43 WT A / + and Repo-LexA::GAD 
> LexAop-hTDP-43 B to LexAop-hTDP-43 WT B / +, respectively). N = 4 for all other groups. 
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II. λN-Conjugated RNA Editase Constructs: 
Reasoning and Design:  
The ultimate goal of these tools is to generate a system by which to mark RNA transcripts from 
different RTE families in a cell type-specific fashion, thereby demarcating the cell type of origin of 
actively expressed RTEs in preparations from whole Drosophila head tissue. The tools described 
below are intended to harness the activity of natural RNA editing enzymes to alter the sequence of 
actively transcribed RTE-derived RNA transcripts in such a way that these sequence changes will not 
alter the natural activity of the element and will be maintained through the transposition cycle all the 
way through the point where the RTE has re-integrated back into the genome. It is hoped that 
expressing these RNA editing enzymes with cell type specificity via the GAL-4/UAS system may 
reveal the cell type of origin of actively transposing RTEs in response to various manipulations by 
performing high coverage DNA sequencing of preparations of whole head tissue. These tools build on 
the in vitro designs developed by Montiel-Gonzalez, MF, et al. in their 2013 PNAS paper, in which 
the authors tethered the catalytic DD of the human ADAR protein to the 22 amino acid λN peptide, 
which normally mediates binding of the λ-phage N protein to boxB RNA hairpins in order to regulate 
antitermination during transcription of λ-phage mRNAs. The DD of ADAR normally catalyzes the 
hydrolytic deamination of A to I, which is read out as G by both translation machinery and 
sequencing technology. This function makes it an ideal tool by which to mark actively transcribed 
RNAs of a known sequence. As the λN peptide binds the short (17 nucleotide) boxB hairpin motif 
with nanomolar efficiency, it makes an excellent tether by which to bring the catalytic activity of the 
ADAR DD to an RNA substrate. Sequence specificity can be introduced into the system by creating a 
“guide RNA” that is both complementary to the desired target sequence and contains a boxB hairpin 
structure (Montiel-Gonzalez et al. 2013). Thus, the guide RNA will localize to actively transcribed 
RNA species via sequence complementarity, the boxB structure embedded therein will be recognized 
by the λN peptide in the λN-DD fusion protein, and this will bring the ADAR DD into close  
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FIGURE 22. The λN-DD system: generating λN-DD constructs for cell type-specific use in 
Drosophila and GFP reporter constructs for functional testing of the λN-DD system in vivo. 
(A) Schematic representation of the λN-DD system [adapted from: (Montiel-Gonzalez et al. 2013)]. 
(B) Dose-response curve of target editing with regard to concentration of λN-hDD in vitro [adapted 
from: (Montiel-Gonzalez et al. 2013)]. (C) Fluorescence micrographs demonstrate that λN-DD and 
guide RNA can restore functional green fluorescence in HEK-293T cells transfected with EGFP 
W58X [adapted from: (Montiel-Gonzalez et al. 2013)].  (D) Electropherograms of sequenced RT-
PCR products of EGFP W58X cDNA from HEK-293 cells transfected with EGFP W58X alone or in 
conjugation with λN-DD and guide RNA. Arrows indicated target site [adapted from: (Montiel-
Gonzalez et al. 2013)]. (E) Schematic of λN-dDD and λN-hDD inserts. (F) Schematic of myr-eGFP 
WT and myr-eGFP W58X inserts. (G) Insertion into pUAST attB. 
  
	 164	
  
Pe
rc
en
t e
d
iti
ng

[N-DD] (nM)
CGCAAATGGGCGGTAGGCGTGC^TCGAGATGGACTACAAGGACGACGATGACAAACTAGT
AAACGCACGAACACGACGACGTGAGCGTCGCGCTGAGAAACAAGCTCAATGGAAAGC
TGCAAACCCAATCGACGACTCGAAGTCGTCATCGATGGAGTTGCCTCAGATACACGCGGAT
ACGATTGGTCGGTTGGTCTTAGAAAAGTTCATGGAAGTAATCAAGGGCCAGGAGGCTTAC
TCGCGTCGAAAGGTATTAGCGGGCATTGTAATGACTGAAAACATGAATTTTTGTGAAGCC
AAAGTTATTTCAGTTTCGACGGGCACCAAGTGTGTCAGCGGTGAGCATATGAGTGTGAACG
GAGCTGTCCTAAATGATTCCCATGCTGAAATAGTCTCCAGGCGTTGTCTTCTCAAATATTT
ATATGCACAGCTGGACCTTCAGTGCAATCAGGCCACAGCATATCAGTCGATTTTCGTGAGG
AATACTGATGGGCAATACCCTTATAAACTAAAATCCGGGGTACATTTCCATTTGTATATAA
ATACAGCACCTTGTGGGGATGCACGGATATTTAGTCCTCACGAAAACGACACTGGTGTTGA
TAAACATCCAAATAGAAAAGCTCGTGGCCAGCTGCGCACCAAAATCGAGTCCGGTGAGGG
GACGATTCCAGTGAAAAGCAGTGATGGTATCCAGACGTGGGATGGCGTATTGCAGGGCCA
ACGCCTGCTAACAATGTCGTGCTCGGATAAAATTGCCCGTTGGAACATCGTGGGCATCCAA
GGCTCACTATTGTCTTCCATAATTGAACCGGTGTACCTGCATTCGATTGTGCTGGGAAGCCT
GTTGCATCCGGAGCACATGTACCGCGCAGTTTGCGGCCGAATTGAGAAGTCCATTCAAGGC
CTGCCACCGCCGTACCATCTGAACAAGCCGCGCCTGGCACTAGTCACTTCGGCCGAGCCGCG
GAATCAGGCCAAGGCTCCCAACTTCGGGATCAATTGGACCATTGGGGACACCGAGCTGGA
AGTGGTGAACTCGCTAACCGGTCGAACCATTGGCGGCCAGGTGTCTCGCATCACAAAGCAG
GCGTTTTTCGTTAAGTATGGATTTCTAATGGCAAACTTGCCCGGTATTTTAGTCCGCAAAG
TAACCACTGACTATGGGCAAACCAAAGCTAACGTTAAAGGACTATCAGATCGCAAAGCTA
GAATTGTTCTCTGCATTCAAGCGAGAAGACCTTGGCAGCTGGCTGAAGAAACCCATTGAA
CAAGACGAGTTCGGTCTTGCCGAACACCATCACCATCACCATTCTAG^ATCCTGTGTGAAA
TTGTTATCCGCT
	 CGCAAATGGGCGGTAGGCGTGC^TCGAGATGGGCAACAAATGCTGCAGCAAGCGACAGGATCAGGAACTGGCACTGGCCTATCCCACTGGGGGCTACAAGAAATCCG
ACTACACCTTTGGCCAGACGCACATCAACAGCAGCGGCGGCGGCAACATGGGCG
GCGTTCTTGGCCAGAAGCATAACAACGGTGGCTCGCTGGACTCGCGCTACACGC
CCGATCCCAATCATCGGGGTCCGTTGAAAATCGGCGGAAAGGGCGGCGTTGAC
ATCATCAGACCACGCGGATCCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGG
GTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGC
GTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTC
ATCTGCACCACCGGCAAGCTGCCCGTGCCCTGACCCACCCTCGTGACCACCCTGA
CCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTT
CTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAG
GACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACCCTG
GTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTG
GGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGAC
AAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGA
CGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGC
CCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAG
ACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCG
GGATCACTCTCGGCATGGACGAGCTGTACAAGTCTAG^ATCCTGTGTGAAATTG
TTATCCGCT
CGCAAATGGGCGGTAGGCGTGC^TCGAGATGGGCAACAAATGCTGCAGCAAGCG
ACAGGATCAGGAACTGGCACTGGCCTATCCCACTGGGGGCTACAAGAAATCCGA
CTACACCTTTGGCCAGACGCACATCAACAGCAGCGGCGGCGGCAACATGGGCGGC
GTTCTTGGCCAGAAGCATAACAACGGTGGCTCGCTGGACTCGCGCTACACGCCCG
ATCCCAATCATCGGGGTCCGTTGAAAATCGGCGGAAAGGGCGGCGTTGACATCA
TCAGACCACGCGGATCCATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGT
GCCCATCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCC
GGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCA
CCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGACCTACGGC
GTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGT
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proximity with the targeted transcript (Figure 22A). The deaminase activity of DD will then convert 
the appropriate A to I within the target of interest, which will be read out as a G.  
The authors functionally tested their system in HEK-293T cells using a GFP reporter. The 
W58X point mutation of eGFP encodes a premature stop codon where a W normally would reside, 
such that no full-length eGFP protein is produced when it is expressed. Importantly, this is due to a 
base conversion of the third “wobble” position in the codon from UGG to UGA such that editing of 
just one base in the mRNA transcript by ADAR DD converts the premature stop codon back to the 
appropriate codon for W, resulting in translation of full-length eGFP protein. After careful testing of 
the parameters of guide RNA positioning with respect to DD catalytic efficiency, the authors were 
able to generate robust expression of full-length eGFP protein when eGFP W58X was co-transfected 
with λN-DD and an eGFP-X guide RNA in vitro (Montiel-Gonzalez et al. 2013) (Figure 22C and 
22D). 
 I have undertaken to develop the λN-DD fusion protein from the original study, which 
employs the DD from human ADAR (λN-hDD), and an analogous fusion protein that employs the 
DD from Drosophila ADAR (λN-dDD), for use in the GAL-4/UAS system such that they may be 
implemented in vivo with cell type specificity. I have subcloned the construct from (Montiel-
Gonzalez et al. 2013) into the pUAST vector, which places it under UAS control. I have generated a 
new construct that replaces the hDD with dDD, and have subcloned this into pUAST as well (Figure 
22E and 22G). The idea behind using the two different DDs is simply to couch for the possibility that 
the dDD may work better in the Drosophila cellular milieu. In order to functionally test these two 
constructs in vivo, I have likewise subcloned both eGFP W58X and a full length, wild type eGFP 
positive control into pUAST (UAS-myr-eGFP W58X and UAS-myr-eGFP WT, respectively) (Figure 
22F and 22G). Both of these GFP constructs carry an N-terminal myristoylation sequence that will 
target the translated protein to the membrane for clean delineation of the morphology of the cell types 
in which they are expressed by confocal microscopy. Finally, I have made use of a vector designed to 
express CRISPR guide RNAs under the Drosophila U6 promoter for the generation of a pU6-eGFP-X  
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guide RNA construct using the eGFP-X guide sequence that was so effective in vitro in (Montiel-
Gonzalez et al. 2013) (Figure 23A). The U6 promoter is used here because it is a strongly expressing 
RNA Pol III promoter, which facilitates the expression of uncapped and non-polyadenylated RNAs. 
Once a Gal4 driver, a λN-DD construct, an eGFP construct, and the eGFP-X guide RNA are all 
present in the same animal, the λN-DD and eGFP constructs will both be expressed in the same cells 
by the Gal4 driver, while the guide RNA will be ubiquitously expressed under pU6. 
 
Validation:  
I have subcloned the two deaminase constructs, λN-hDD and λN-dDD, into pUAST such that they 
will be under UAS control in the transgenic animal. Subcloning was validated by Sanger sequencing 
and both constructs were sent out for injection to generate transgenic fly lines according to standard 
protocol. I further subcloned the myr-eGFP WT and myr-eGFP W58X constructs for functional 
testing of the two deaminase constructs into pUAST as well. These were also validated by Sanger 
sequencing and sent out for injection. Both the pair of deaminase constructs and the pair of eGFP 
constructs were attP/attB integrated to minimize expression level differences within each pair due to 
variations in the genomic context of the insertion site. Transformants were again validated by PCR of 
genomic DNA. I have gone on to outcross two transformant lines of each the λN-hDD and λN-dDD 
constructs to our in-house wild type fly strain for 5 generations, such that if any of these lines proves 
effective they will be ready for use in sequencing experiments.  
I attempted to generate a pU6-eGFP-X guide RNA transformant line with which to test the 
effectiveness of the λN-hDD and λN-dDD constructs in vivo in combination with the UAS-myr-eGFP 
W58X reporter. Given that my personal communication with Dr. Rosenthal revealed that expression 
levels of the guide RNA appeared to be rate-limiting in in vitro tests of this system, I used the most 
highly expressing pU6 expression vector I could find. I succeeded in generating a pU6-eGFP-X guide 
RNA construct with this vector, however transformant lines were near impossible to generate and the 
only one that the injection facility was ever able to make never was confirmed by PCR validation. I  
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FIGURE 23. Generating a pU6-eGFP-X guide RNA for use in Drosophila and functional testing 
of the λN-DD system in neurons and glial cells of the fly CNS. 
(A) Schematic representation of pU6-eGFP-X guide RNA cloning strategy. (B) Functional testing of 
λN-DD system in neurons (under MB247-GAL4) and glia (under Repo-Gal4) of the Drosophila CNS. 
The two GFP constructs appear to be working as expected, as there is a high level of GFP signal in 
the positive control groups (UAS-myr-eGFP WT) and very little GFP signal in the groups carrying 
GFP with a premature stop codon (UAS-myr-eGFP W58X). However, no editing of the GFP W58X 
reporter is detectable by either λN-dDD or λN-hDD in either neurons (MB247-GAL4 > UAS-λN-
dDD + pU6-eGFP-X + UAS-myr-eGFP W58X and MB247-GAL4 > UAS-λN-hDD + pU6-eGFP-X + 
UAS-myr-eGFP W58X) or glia (Repo-GAL4 > UAS-λN-dDD + pU6-eGFP-X + UAS-myr-eGFP 
W58X and Repo-GAL4 > UAS-λN-hDD + pU6-eGFP-X + UAS-myr-eGFP W58X). N = 3-4 per 
group. 
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tested this single guide RNA transformant line with the eGFP and deaminase constructs under two 
separate Gal4 drivers, and while is appears that UAS-myr-eGFP WT and UAS-myr-eGFP W58X are 
working properly, I was not able to detect any editing of UAS-myr-eGFP W58X by either λN-hDD or 
λN-dDD (Figure 23B). My intuition is that the guide RNA transformant line was a rare escaper that 
does not actually carry pU6-eGFP-X, and that we are running up against an RNA toxicity issue with 
the high levels of expression of this short guide RNA from the constitutive U6 promoter. I am in 
possession of another pU6 vector that does not express at quite such high levels, and it would be a 
simple matter to place the eGFP-X guide sequence into this vector and send it out for injection. 
Finally, I have generated 2 guide RNA sequences targeting highly conserved A residues in gypsy Gag 
and 2 in gypsy Pol based on the parameters for guide RNA positioning laid out in (Montiel-Gonzalez 
et al. 2013), and am in possession of the oligonucleotides necessary to clone these sequences into the 
appropriate pU6 vector for testing. I therefore believe that if any of the λN-hDD or λN-dDD 
transformant lines prove effective in the eGFP assay, it should be relatively quick and easy to move 
directly to testing efficacy on marking transcripts derived from the gypsy RTE in a cell type-specific 
fashion via sequencing technology. 
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III. Tissue Collections for RNA Sequencing: 
Reasoning and Design:  
Given the glial specificity of hTDP-43’s effects on gypsy presented in Chapter 3, we are interested in 
the possibility of cell type-specific activation of different TE classes in different cell types in response 
to TDP-43 pathology. As loki(IR) provides such dramatic rescue of hTDP-43’s effects on lifespan in 
both neurons and glia, while gypsy expression only appears to be induced by hTDP-43 expression in 
glia, this kind of cell type specificity seems to be a strong possibility. Such a phenomenon could 
reflect the different epigenetic environments or different somatic TE composition of different cell 
types, or another as-of-yet unimagined explanation. In order to address whether this possibility is in 
fact a reality, I have collected large quantities of flies expressing hTDP-43 in either neurons or glia 
along with appropriate control groups at both young and aged time points (Figure 24A). This sample 
set is intended to generate large-scale RNA preps from whole head tissue with which to perform both 
RNA sequencing and small RNA sequencing. In addition to addressing the question of whether 
hTDP-43 expression induces the expression of different TE types in different cell types, small RNA 
sequencing from these groups would provide insight as to whether hTDP-43 expression interferes 
with siRNA silencing of TEs by interrupting siRNA biogenesis or somewhere downstream, such as 
the localization of loaded Ago2/RISC to the target RNA. 
 
Validation:  
We have a tried-and-true protocol for isolating large quantities of Drosophila heads from whole 
frozen flies in the Dubnau lab. Lisa Prazak, a post-doc in our lab, is currently working with Nikolay 
Rozhkov in Molly Hammell’s lab to generate the small RNA libraries diagrammed in Figure 24B. Dr. 
Rozhkov has extensive experience with both small RNA sequencing and RNA sequencing from 
Drosophila tissue from his previous experience in Greg Hannon’s lab, and once the libraries have 
been sequenced they will be analyzed by Molly Hammell’s lab as part of our standing collaboration. 
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FIGURE 24. Sample sets for RNA sequencing comparing neuronal versus glial expression of 
hTDP-43 in Drosophila head tissue. 
(A) Schematic representation of the sample set for large-scale RNA preps from head tissue of flies 
expressing hTDP-43 in neurons versus glia and genetic controls at young and aged time points. (B) 
Small RNA sequencing library preps currently being processed by Dr. Prazak. 
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CHAPTER 5 – Conclusions and Perspectives: 
 
 In the Introduction I have discussed the ways in which TEs have exerted a powerful influence 
over the evolution of their host genomes. In so doing they have been co-opted to perform critical roles 
in genome regulation, likely contributing to morphological and neurological diversity within the 
mammalian lineage (van de Lagemaat et al. 2003; Sandelin et al. 2004; Lindblad-Toh et al. 2005; 
Woolfe et al. 2005; Polak and Domany 2006; Thornburg et al. 2006; Lowe et al. 2007; Mikkelsen et 
al. 2007), and endowing the acquired immune system with the flexibility to respond to unpredictable 
invasion of foreign antigens via the V(D)J recombination mechanism (Kapitonov and Jurka 2005; Sen 
and Oltz 2006; Slotkin and Martienssen 2007). We now know that they are active during brain 
development as well (Muotri et al. 2005; Garcia-Perez et al. 2007b; Coufal et al. 2009; Kuwabara et 
al. 2009; Muotri et al. 2009), and that this activity is likely to be of functional relevance as novel 
somatic L1 insertions tend to transpose near genes important for nervous system function (Muotri et 
al. 2005; Baillie et al. 2011; Upton et al. 2015). Indeed, removing the ability to repair DNA damage in 
mice results in embryonic lethality with massive defects in both lymphogenesis and neurogenesis 
(Gao et al. 1998), revealing a critical window in the development of these two systems in which the 
repair of DSBs is of paramount importance. However, we also know that the unbridled activity of 
even one active TE class is enormously destructive, as in the case of hybrid dysgenesis (Schaefer et 
al. 1979; Castro and Carareto 2004). Here, introduction of one novel TE into the genome results in 
sterility and complete destruction of the germline tissue (Schaefer et al. 1979). I have also presented 
data to the effect that activation of RTEs by TDP-43 protein pathology causally contributes to 
physiological deterioration and that the cellular toxicity induced by TDP-43 pathology is mediated by 
Chk2 signaling following DNA damage. We know that TDP-43 protein pathologies arise sometime at 
or just after middle age, and that this happens, for the most part, in individuals with no known genetic 
lesion precipitating pathology (Arai et al. 2006; Neumann 2009; Ling et al. 2013). In fact, this is a  
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common theme for most neurodegenerative diseases. So what is it about the aged somatic 
environment that makes the nervous system so susceptible to pathology? And how can TEs, whose 
regulated activity appears to be constructive during neuronal development, become a driving 
destructive force once someone has reached middle age? Below, I will discuss the evolutionary theory 
of aging and how TEs and TE control mechanisms fit into this framework. Finally, I will discuss how 
this relates to what we know about TEs in the nervous system and I will use both my thesis work and 
other recent work from the Dubnau lab to build a model of how TDP-43 pathology fits into the 
context of normal neurological decline in wild type aging. I believe this exercise has the potential to 
provide insight into the pathological prognosis of neurodegenerative disease in general, as TEs have 
been linked to many different types of neurodegenerative disease in recent years. 
 
I. What is Senescence? 
 Selective pressure has shaped all of the beneficial functions that TEs have been described to 
participate in thus far, including the evolution of the linear chromosome, regulation of the deployment 
of genetic information, and adaptability of the acquired immune system. By its very nature, selective 
pressure finds fitness maxima – perhaps in individuals with better immune systems or more complex 
nervous systems that are better equipped to survive in their environments and provide better care for 
their mates and their offspring. However, it is readily apparent that as an organism ages, it will 
inevitably become less fit until it succumbs to environmental stressors and passes away. The first 
theory of aging was published in 1891 by August Weissman, in which he postulated that death of 
older individuals of the population may have evolved for the benefit of the species such that younger 
individuals may have more access to resources, thus enabling the evolutionary process (Weismann 
1891). This theory implies that individuals undergo a type of “programmed death mechanism” to 
ensure a limited life span. Contemporary arguments against this theory held two major objections, 
namely: (1) animals living in the wild rarely live long enough to die of old age. Therefore, the  
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FIGURE 25. The reproductive probability distribution and the response of populations exposed 
to stressors. 
(A) The relationship of age to the reproductive probability distribution. The solid line is the 
reproductive probability distribution; the dashed line indicates the proportion of the total probability 
that remains after any given age [adapted from: (Williams 1957)]. (B) Hormesis is experienced in 
populations with a low dose of a given stressor [adapted from: (Parsons 2005)]. 
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mechanism would scarcely, if ever, have an opportunity to operate, raising questions as to how and 
why it would have a chance to evolve in the first place. (2) Darwinian selection is, by definition, 
survival of the fittest. Any organism that lives longer and deteriorates less readily over time will leave 
behind more offspring, thus actively negating the concept of programmed death (Comfort 1956; 
Williams 1957).  
However, we undoubtedly observe a progressive aging process, a phenomenon that has been 
termed “senescence.” As senescence is subject to genetic variability (Gonzales 1923; Kallmann 
1948), later theorists began to conceptualize it as a negative trait. However, its pervasiveness dictated 
that a secondary force must be at play that “favors its [senescence’s] development in such a way that 
the observed variations in senescence reflect variations in the balance between these two forces” 
(Williams 1957). By the mid-1950’s, theorists were beginning to understand the aging process as 
resulting from depreciation of selective pressure with increasing age (Bidder 1932; Haldane 1941; 
Medawar 1953; Comfort 1954; Medawar 1955; Comfort 1956; Williams 1957), an effect that makes 
it appear highly variable and stochastic. Both Peter Medawar and George Williams further elaborated 
on this idea using the concept of a reproductive probability distribution (Figure 25A), which is based 
on the equation W = (1 + m1p1) + (1 + m2p2) + … (1 + mnpn); where m = the magnitude of the effect 
and p = the relevant proportion of the reproductive population (Medawar 1953; Medawar 1955; 
Williams 1957). 
 The reproductive probability distribution takes into account that there is always a cumulative 
probability of death even in the absence of senescence, as survival is always more likely to age A than 
to age A+1.  Since reproductive probability at a given age is a function of survival to that age, this 
results in a natural decay in reproductive probability. Therefore, whenever there is a conflict of 
interest natural selection will always favor youth over old age, as any genic effect that arises in old 
age will inherently have the smaller p-value. As p begins to drop off at reproductive maturation, 
theoretically this point should denote the onset of senescence processes (Medawar 1953; Medawar 
1955; Williams 1957). As each new genic effect in turn is evaluated based on the current reproductive  
	 185	
  
	 186	
probability distribution, a previously established senescence factor actually enables the establishment 
of additional senescence factors, resulting in a self-perpetuating exacerbation of senescent 
deterioration (Medawar 1953; Medawar 1955; Williams 1957). In this manner, natural selection 
prefers maximizing vigor in youth, and this is intrinsically accompanied by a progressive decline in 
vigor, or senescence, in adult life into old age (Medawar 1953; Medawar 1955; Williams 1957). It is 
important to note that such a model in fact argues against any one archetypal “senescence gene” 
acting within a population, as its presence would induce positive selection for genes that would 
mitigate or postpone its adverse effects (Williams 1957). 
 This model leads to two predictions about the nature of the senescence process. The first, 
advocated by Peter Medawar, is that senescence reflects either the loss of beneficial genic effects or 
gain of harmful genic effects (or some combination thereof) in later life due to a relaxation in 
selective pressure to either maintain or remove them (Medawar 1953; Medawar 1955). The second, 
put forth by George Williams, states that senescence reflects pleiotropic genic effects at different ages 
since the selective value of all genes are based on their effects on total reproductive probability 
(Williams 1957). In this case, both the inflection and the timing of the effect are important. An 
advantage bestowed before or during the period of maximum reproductive probability would increase 
the total reproductive probability more than an equivalent disadvantage in later life would reduce it 
(Williams 1957). The latter of these two predictions is commonly referred to as negative or 
antagonistic pleiotropy (Williams 1957; Parsons 2007).  
 Organisms in the wild are faced with energetically or nutritionally inadequate, harsh 
environments, thus their survival during the aging process is mainly dictated by their ability to 
efficiently respond to the metabolic and energetic challenges presented to them (Capy et al. 2000; 
Parsons 2005; Parsons 2007). A fitness-stress continuum is usually employed to express variation in 
the severity of environmental stressors on natural populations, wherein the reciprocal of the stress 
intensity relates to the average fitness of an individual within the population (Parsons 2005; Parsons 
2007). If stressors are too extreme, the organism cannot survive. Fitness maxima are observed under  
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conditions of mild stress, with commonly cited examples including caloric restriction, physical 
activity, temperature, et cetera. Such maxima result in prolonged longevity, an effect that is titled 
hormesis (Capy et al. 2000; Parsons 2005; Parsons 2007; Zhu et al. 2014) (Figure 25B). Senescence, 
then, is a product of benign environments. Perhaps the best evidence to test predictions derived from 
the reproductive probability distribution come from humans living in modern, civilized societies 
where healthcare and technology have effectively relaxed selection for stress resistance, resulting in 
increased survival and reproduction of relatively unfit individuals who would have been poorly 
equipped to survive in hunter-gatherer environments, and increased median age and life expectancy, 
resulting in massive expansion of our post-reproductive population. Understanding senescence is, 
therefore, the most pressing medical issue of our age (Tucker et al. 1999; Martin 2007). 
 
II. TEs and Senescence: 
 There is no need to believe that the theories presented above are restricted solely to the 
effects of protein coding genes. If the genomic revolution has taught us anything, it is that we should 
look more comprehensively, to understand the non-coding and epigenetic context of the coding 
portions of our genome in order to come to a full appreciation of genetic-environmental interactions. 
Many theories regarding functional decline during aging invoke the progressive inability to maintain 
cellular structure (Macieira-Coelho 1991; Kennedy et al. 1995; Oberdoerffer and Sinclair 2007; 
Wilson et al. 2008; Wood and Helfand 2013). Indeed, age effects on chromatin structure are well 
documented (Wood and Helfand 2013). While the signs of gains or losses of individual activating or 
repressive histone marks vary in different studies and different systems, recent evidence depicts 
global degradation of chromatin architecture as a hallmark of aging, with dramatic implications for 
both gene and TE activity (Wood et al. 2010; De Cecco et al. 2013b; Wood and Helfand 2013). 
 One of the earliest systems developed for cellular aging studies is yeast replicative 
senescence. The phenotypic read out for this system is the number of times a mother cell can divide to  
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produce a daughter cell before entering into a senescent state (Wood and Helfand 2013). Early studies 
of yeast replicative senescence described heterochromatin loss at ribosomal DNA repeats, the mating 
type locus, and telomeres in senescent cells (Kim et al. 1996; Smeal et al. 1996; Kennedy et al. 1997). 
Such observations prompted a preliminary heterochromatin loss model of aging wherein a weakening 
or breaking down of critical constitutive heterochromatin results in detrimental changes to cellular 
homeostasis; with increased transcriptional noise obscuring important cellular functions and precious 
cellular energy being taken up synthesizing unimportant, or even detrimental transcripts or repairing 
other types of damage (Smeal et al. 1996; Villeponteau 1997; Tsurumi and Li 2012). Indeed, total 
histone protein levels are diminished in senescent yeast cells, and overexpressing histone proteins can 
artificially suppress senescence (Feser et al. 2010). 
 A more recent model of cellular senescence has emerged which exploits the replicative 
senescence of cells in tissue culture. Cells will only divide a finite number of times under these 
conditions before entering into a senescent state (Wood and Helfand 2013). Various senescence-
dependent histone mark alterations have been described in this system, and reductions in total histone 
protein levels are also observed (O'Sullivan et al. 2010; O'Sullivan and Karlseder 2012; Ivanov et al. 
2013; Shah et al. 2013). These cells also develop characteristic γH2Ax-positive non-pericentromeric 
SAHF (Narita et al. 2003; Zhang et al. 2005; Kosar et al. 2011; Chandra et al. 2012). A global study 
by DeCocco et al (2013) implemented the FAIRE technique (Giresi and Lieb 2009) on normal human 
diploid fibroblasts to map genome-wide conformational change on chromatin state in senescent 
versus actively growing cells (De Cecco et al. 2013b). It is important to note here that FAIRE can 
only mark activation not repression, due to the fact that formaldehyde cross-linking is more efficient 
on nucleosome-bound DNA, resulting in sequencing of non-crosslinked DNA that is predominantly 
open chromatin. The results were quite remarkable – FAIRE profiles of senescent cells were 
noticeably smoothened in comparison to growing cells (Figure 26A.3), whose genomes are replete 
with topography of both closed and open chromatin. This effect is mediated by both FAIRE signal 
loss in active, gene-rich regions of chromatin (Figure 26A.2) and FAIRE signal gain in  
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FIGURE 26. Activating and repressive chromatin structure ‘smoothens’ with age in an in vitro 
replicative senescence model and Drosophila organismal aging, while TE activity negatively 
impacts lifespan in Drosophila. 
(A) FAIRE signal ‘smoothing’ in senescent normal human diploid fibroblasts. (A.1) Gain of FAIRE 
enrichment in areas marked by repressive H3K9me3 histone modification, with simultaneous (A.2) 
loss of FAIRE enrichment in regions marked with activating H3K4me3 histone modification in 
senescent (red) versus early passage (blue) cells as compared to randomized controls. (A.3) The 
genome-wide FAIRE enrichment profile with the activating histone mark H3K4me3 demonstrates a 
dramatic reduction in FAIRE signal enrichment in senescent cells compared to their early passage 
counterparts [adapted from: (De Cecco et al. 2013b)]. (B) Chromatin ‘smoothing’ in aged Drosophila 
melanogaster. The mean log2 ChIP signal is shown on a composite gene representing the exonic 
regions of all ~14,000 genes in the Drosophila melanogaster genome, scaled from the TSS to the 
transcriptional stop (100%). Loss of activating H3K4me3 histone modifications (B.2) and gain of 
repressive H3K36me3 histone modifications (B.3) are observed in 40 day old flies (red) compared to 
their 10 day old counterparts (blue) [adapted from: (Wood et al. 2010)]. (C) Activating the P-element 
transposon significantly shortens lifespan in Drosophila melanogaster. Lifespans are shown at 18 °C 
(bottom) and 25 °C (top) for females (white bars) and males (hatched bars) of parental strains 
carrying the second chromosome of the Birmingham strain, with 17 non-autonomous P elements 
(Birmingham-2) or a P-element with an in-phase deletion that renders its transposase inactive at 18 
°C but somatically active and unable to act on its own element at 25 °C (P delta 2,3) in the Canton-S 
genetic background. The mean of the two parental strains for each sex is also displayed (MEAN), as 
is that for the F1 progeny (F1) at each temperature [adapted from: (Driver and McKechnie 1992)]. 
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heterochromatic, gene-poor regions (De Cecco et al. 2013b) (Figure 26A.1). Centromere structures 
relax and enlarge in the senescent state, with a concomitant increase in transcription of satellite 
sequences. Similarly, the heterochromatin surrounding Alu, SVA, and L1 elements becomes 
relatively more open, with a more pronounced effect on more evolutionarily recent elements. This 
effect is accompanied by increased transcription of these elements, and even active transposition, as 
an increase in genomic copy number of specific elements is observed in late-stage senescent cells (De 
Cecco et al. 2013b). Some of these effects arise early in senescence, while others such as TE 
mobilization only become prevalent at later stages, perhaps due to the prerequisite of overcoming 
multiple redundant repressive mechanisms (De Cecco et al. 2013b). 
Similar age-dependent chromatin effects have been reported at the organismal level in 
Drosophila. Wood and colleagues (2010) performed ChIP on young and aged flies for the activating 
marks RNA Pol II and H3K4me3 and the repressive mark HP1, followed by whole genome tiling 
microarrays. A similar “chromatin smoothing” was observed in aged flies, although due to the way 
these data were generated and normalized, absolute values could not be measured and therefore it was 
impossible to conclude whether H3K4me3 or HP1 were gained or lost in heterochromatic regions 
with age (Wood et al. 2010) (Figure 26B.1 – 26B.3). Since neither of these two studies have 
determined the cause of this “chromatin smoothing” phenotype, they raise questions regarding 
whether the phenotype reflects general regulatory decay with age or some type of adaptive or 
compensatory effect, such as intensified efforts to maintain TE repression “spilling over” into the rest 
of the genome (Wood et al. 2010). If this phenotype indeed reflects general regulatory decay, it does 
seem to fit quite well with Peter Medawar’s prediction that senescence reflects loss of beneficial 
genic functions or gain of harmful genic functions due to relaxation of selective pressures with age. 
If, on the other hand, it reflects intensified efforts to suppress TEs spilling over into the rest of the 
genome, this effect could be interpreted as mitigating action intended to suppress the archetypal 
antagonistic pleiotropic activity of TEs in old age. 
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DNA methylation and DSB repair processes also begin to decay in old age (Li et al. 2008; De 
Cecco et al. 2013b). Both in vivo tissues and cell culture replicative senescence models display 
reductions in total genomic DNA methylation (Sedivy et al. 2008), likely due to a reduction in levels  
of the DNA methyltransferase DNMT1 as cells approach senescence (Young et al. 2003). Curiously, 
these effects are mostly due to reductions in methylation of repetitive DNA (Sedivy et al. 2008). 
NHEJ becomes more error-prone and less efficient in senescent cells (Seluanov et al. 2004), and 
defects in NHEJ have been observed in both the brains of aging rats (Ren and Pena de Ortiz 2002; 
Vyjayanti and Rao 2006) and in Alzheimer’s patients (Shackelford 2006). Moreover, reports from the 
literature suggest that an organism’s age as a function of its lifespan appears to predict frequency of 
chromosomal aberrations more accurately than strict chronological time (Crowley and Curtis 1963; 
Martin et al. 1985; Ramsey et al. 1995; Tucker et al. 1999; Li et al. 2007; Li et al. 2008). Such 
observations leave us with a type of “chicken-or-the-egg” problem in determining the causality of TE 
disregulation in cellular senescence: either a slow down of global cellular regulatory processes 
ultimately proves toxic to cells during senescence, with TE activation simply being an annoying side 
effect; or the destructive activation of TEs, as a consequence of this general biological slow down, 
feeds forward to contribute to cellular decline and eventually overwhelms the system, ultimately 
causing the cell to succumb. 
A series of observations from highly divergent organisms cast an incriminating light on TEs 
and implicate mobile elements in causally contributing to cellular senescence. Over 20 years ago, 
Driver and McKechnie (1992) reported that post-developmentally activating the P-element TE 
significantly reduces lifespan in Drosophila (Figure 26C). The authors also noted increased genomic 
copy number of P-element and Copia TEs in aged wild type flies (Driver and McKechnie 1992). 
More recently, a study by Maxwell and colleagues (2011) reported that the yeast LTR element Ty1 
exhibits elevated transposition in very old populations, with new transposition events associated with 
chromosomal rearrangements in an S cerevisiae chronological aging model. Treatments and 
mutations that reduce Ty1 retrotransposition were found to attenuate age dependent increases in  
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chromosome loss and loss of heterozygosity events (Maxwell et al. 2011). Finally, a study by Wang 
et al. (2011) found that elevated Alu transcription induces loss of efficient DNA repair in 
pericentromeric chromatin as well as formation of persistent SAHF-like γH2Ax-positive DNA 
damage foci in ex vivo aging. Amazingly, stable suppression of Alu transcription by shRNA knock-
down was shown to cause cells to revert to an “iPS-like” phenotype, restore their proliferative 
faculties, and elevate transcript levels of Nanog and Oct4, two critical pluripotency regulators (Wang 
et al. 2011).  
TE derepression alone can be massively mutagenic and deleterious to the cell (Belgnaoui et 
al. 2006; St Laurent et al. 2010). This destructive behavior has been experimentally validated in an in 
situ system designed to recapture de novo TE insertions of a liberated L1 element in somatic tissue 
culture. Using this system, Symer et al. (2002) documented “numerous L1 element inversions, exon 
deletions, extra nucleotide insertions, a chromosomal inversion, and comobilization of flanking 
sequence” (Symer et al. 2002); recapitulating many types of genomic instability long attributed to 
TEs. High copy numbers of DNA elements have been shown to induce DSBs in human cell lines 
(Belgnaoui et al. 2006), while overexpression of L1 from muticopy plasmids not only produces 
elevated quantities of DSBs, but also results in γH2Ax foci reminiscent of SAHF (Gasior et al. 2006). 
Furthermore, in vitro overexpression of the L1 ORF2 endonuclease results in DNA damage, cellular 
senescence, and apoptosis in human cells (Belgnaoui et al. 2006; Wallace et al. 2008). As mutations 
that alter lifespan commonly occur in genotoxic stress-response and DNA repair pathways, the 
capacity to repair DNA damage is a key player in determining lifespan (Capri et al. 2006; St Laurent 
et al. 2010). If TEs are even partially responsible for such DNA damage, they may indeed be the 
spark that catalyzes deterioration, and ultimately demise, in senescence processes (St Laurent et al. 
2010). Such effects may be particularly salient to aging nervous systems, which are composed of 
mostly post-mitotic cells. Taken in this light, TEs, not protein-coding genes, may act as the 
quintessential antagonistic pleiotropic elements.  
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III. The Two-Hit Hypothesis of Neurodegeneration: 
 In his definitive essay on natural selection and aging, George Williams states four 
preconditions for his theory of antagonistic pleiotropy: “(1) A soma that is essential to reproductive 
success but no part of which is passed on in either sexual or asexual reproduction. (2) Natural 
selection of alternative alleles in a population. (3) Pleiotropic genes of a special sort. It is necessary to 
postulate genes that have opposite effects on fitness at different ages, or, more accurately, in different 
somatic environments. (4) Decreasing probability of reproduction with increasing age” (Williams 
1957). All four of these preconditions directly describe TE activity with regard to nervous system 
function in aging human populations. (1) Properly functioning neural cells and nervous systems 
collectively are on the whole a pre-requisite for reproductive success in modern human populations, 
but no part of the nervous system is passed on by either sexual or asexual reproduction. (2) As 
described in the Introduction, we know that natural selection does in fact act on allelic variations of 
TEs; indeed this phenomenon is so robust as to have resulted in massive innovations in basic genome 
structure and function. Given the importance of neuronal function to reproductive success in human 
populations, the effects of TE mobilization on brain function should be subject to selective pressures 
as well. (3) TEs’ activity with regard to the nervous system fits William’s definition of a ‘special sort’ 
of pleiotropy amazingly well. As described in the Introduction, cell type-specific, regulated 
mobilization of specific classes of TEs to genomic regions proximal to nervous system genes is 
observed in the somatic environment of neurodevelopment and neuroproliferation, leading many to 
postulate a regulatory role for the resulting somatic mosaicism that is likely to endow the nervous 
system with some positive benefit or function. However in the somatic environment of the aging 
brain (see below) more general expression of many types of TEs is observed, likely due to age-related 
deterioration of TE suppression mechanisms. This type of TE activity potentially contributes to age-
related neuronal decline in wild type animals and has been shown to causally contribute to toxicity in  
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neurodegenerative disease. (4) Human populations are, of course, subject to decreasing probability of 
reproduction with increasing age. 
 A recent paper from the Dubnau lab has demonstrated that TEs do behave according to 
Williams’ negative pleiotropy model in the nervous system of normally aging, wild type Drosophila 
(Li et al. 2013). This work showed that transcript levels of TEs of different classes are elevated in 
head tissue of aged flies, and that in the case of the gypsy ERV, both age-dependent accumulation of 
Env protein and de novo genomic re-integration events are observed in the brains of aged animals. 
This effect appears to be mediated by the siRNA system, as loss of function of Ago2 (Figure 3) 
accelerates TE expression in the brain and shortens lifespan. These results are consistent with 
observations from replicative senescence, chronological aging, and ex vivo aging studies (Driver and 
McKechnie 1992; Wood et al. 2010; Maxwell et al. 2011; Wang et al. 2011; De Cecco et al. 2013b). 
Furthermore, aging effects on TE expression in the Drosophila nervous system appears to have 
functional consequences in vivo, as loss of function of Ago2 was demonstrated to exacerbate age-
dependent memory impairment as measured by a sensitive learning assay (Li et al. 2013). This result 
indicates that the loss of suppression of TEs induced by loss of function of Ago2 may contribute to 
age-dependent neuronal decline.  
The idea that unchecked TE activity can negatively impact nervous system function is 
underscored by the discovery that a reduction in MeCP2, a protein involved in global DNA 
methylation mutations in which are responsible for Rett’s disease, can induce high levels of both L1 
element transcription and retrotransposition (Muotri et al. 2010). Rett’s syndrome is a post-natal 
neurological disorder that occurs almost exclusively in females, is characterized by repetitive arm 
movements, and is frequently found to be co-morbid with epileptic seizures. The disease negatively 
impacts diverse neurological functions such as the ability to speak, walk, and socially interact (Dolce 
et al. 2013). The global symptomology, as well as early onset and progressive decline of Rett’s 
disease appear to be consistent with the immediate negative impacts of global decreases in repressive 
DNA methylation due to abnormal levels of MeCP2 (Lyst and Bird 2015). Accordingly, higher levels  
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of L1 transcripts and de novo transposition events are observed in both brain tissue taken from, and 
NPCs derived from, patients diagnosed with Rett’s disease who carry documented mutations in 
MeCP2 in comparison to age-matched controls. This effect was not observed in fibroblasts or heart 
tissue of the same patients, demonstrating that TEs can be affected in a tissue specific manner in 
response to disease-causing mutations and that the nervous system may be particularly susceptible 
(Muotri et al. 2010).  
The fact that neurodegenerative diseases display an onset of symptoms at or soon after 
middle age, and therefore after the peak of maximum reproductive potential, suggests that similar to 
the majority of cancer cases they are on the whole a result of hapless collapse of function during 
senescent deterioration. The genetic and symptomological diversity of this set of diseases, and the 
persistent fact that age itself remains the greatest risk factor, strongly indicate that antagonistic 
pleiotropy at least partially accounts for neurodegenerative etiology. Further emphasizing this point, 
genetic predisposition accounts for only a minor percentage of most neurodegenerative diseases while 
the vast majority fall under the ‘sporadic’ category, with no known disruption in protein-coding genes 
contributing to pathogenesis. That we observe this suite of diseases separate from 
neurodevelopmental diseases speaks to a singular susceptibility of the nervous system to the 
progressively dilapidated cellular milieu and unstable genetic climate intrinsic to advanced age. As 
noted in the previous section, a body of evidence assembled from studies of normal aging in a variety 
of systems argues that TEs, in fact, may act as the consummate antagonistic pleiotropic factor. TE 
involvement has been reported in a diverse set of neurodegenerative diseases (Lathe and Harris 2009; 
Muotri et al. 2010; Greenwood et al. 2011; Kaneko et al. 2011; Li et al. 2012; Tan et al. 2012; Li et 
al. 2015) and has beenn shown to causally contribute to toxicity in a subset of neurodegenerative 
diseases (Kaneko et al. 2011; Tan et al. 2012), suggesting that it may represent a common underlying 
factor. As the vast majority of studies have either actively or passively ignored TEs by design, it is 
likely that the existing literature only scratches the surface.  
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Recent work from the Dubnau lab, and my thesis work presented herein, use complimentary 
approaches to directly address the role of TEs in TDP-43 protein pathologies. From these two studies 
we can glean some understanding of how TDP-43 pathology, which precipitates rapid and incurable 
neurodegenerative decline in mostly otherwise genetically normal individuals around middle age, fits 
into the context of normal brain aging. Bioinformatically profiling hTDP-43’s TE binding partners 
and determining how they are effected in both rodent genetic models of TDP-43 protein pathology 
and human patient tissue (Li et al. 2012) allows us to determine how prevalent and robust effects of 
TDP-43 pathology are with respect to TEs. Mechanistic studies in Drosophila provide a deeper 
understanding of how and why such effects result in rapid deterioration and, ultimately, cell death. 
Combining these analyses allows us to build a framework with which to interpret both normal 
neurological decline in wild type aging (Figure 27A) and gain new insights into the pathological 
prognosis of TDP-43 protein pathologies (Figure 27B), with broader implications for many other 
neurodegenerative diseases as well. 
As the individual ages, general chromatin structure begins to deteriorate, as observed in both 
replicative senescence and chronological and organismal aging models (Figure 27A: 1). However, 
there is a secondary PTGS system at play in somatic tissue such as the brain that is capable of 
suppressing TEs. For a very long time in a healthy individual, the siRNA system (Figure 27A: 2) is 
able to compensate for loss of heterochromatic silencing with regard to suppressing TEs (Figure 27A: 
3). We know this from two pieces of data: first, in CNS neurons of control flies the fidelity of a 
functional genetic reporter of siRNA-mediated silencing remains robust out to old age in vivo, and 
second, levels of DCR-2 and Ago2 also remain high – if anything they display a slight but statistically 
significant increase in head tissue of old flies in comparison to their younger counterparts (Figure 
13D.1 – 13D.3). Indeed, the upward inflection I observe in DCR-2 and Ago2 levels in the brains of 
old flies may be indicative of this compensatory mechanism. However, as heterochromatin continues 
to deteriorate in the healthy individual, persistent, simmering low-level TE activity eventually reaches  
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FIGURE 27: The two-hit hypothesis of neurodegeneration.  
(A) Normal neurological decline in wild type aging. (A.1) Chromatin architecture degrades with age 
[taken from: Figure 26A.3]. (A.2-1.4) siRNA silencing remains robust out to old age [taken from: 
Figure 14B, OK107 > GFP + GFP(IR) +tdTomato]. (A.5) TEs remain suppressed out to aged time 
points [taken from: Figure 12C, ELAV > hTDP-43, 19-25 Days].  
(B) TE activation in TDP-43 pathology. (B.1) Chromatin architecture degrades with age [taken from: 
Figure 26A.3]. (B.2-B.4) siRNA silencing is eroded with hTDP-43 expression [taken from: Figure 
14B, OK107 > GFP + GFP(IR) + hTDP-43]. (A.5) TEs are precociously and aggressively de-
repressed in response to simultaneous loss of heterochromatin and siRNA silencing [taken from: 
Figure 12C, Repo > hTDP-43, 19-25 Days].  
Numbers in (A) and (B) correlate to references in the text. 
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a boiling point at which it overwhelms the ability of the siRNA system to keep it suppressed (Figure 
27A: 4). This results in increased expression of TEs with age and, eventually, de novo transposition 
events. We observe this effect as detectable new inserts, as described in CNS neurons of aged wild 
type flies by (Li et al. 2013), or the notable increases in genomic TE copy number and gross 
chromosomal abnormalities frequently reported with extreme old age in cells or organisms that are 
otherwise completely genetically normal (Driver and McKechnie 1992; Li et al. 2008; St Laurent et 
al. 2010; Maxwell et al. 2011; De Cecco et al. 2013b; Wood and Helfand 2013). The normal loss of 
control of general TE activity once the siRNA system is finally overwhelmed (Figure 27A: 5) could 
easily contribute to the multifaceted negative heath effects we are accustomed to expect to 
accompany extreme old age (Tucker et al. 1999; Martin 2007). 
In normal brain tissue of both rodents and humans, TDP-43 protein binds promiscuously to 
RNA transcripts derived from many different classes of TEs (Li et al. 2012). Both overexpressing 
hTDP-43, which has been documented to replicate cellular protein pathology similar to that observed 
in human post-mortem patient tissue, and knocking down the mouse ortholog of TDP-43 in rodent 
brain tissue result in a massive and general increase in transcription of a wide variety of TEs (Li et al. 
2012). We are therefore able to deduce that TDP-43 is involved in TE suppression in normal adult 
mammalian brain function. Moreover, it appears that TDP-43 pathology is likely to have its effects in 
a manner similar to a toxic dominant negative, with overexpression or nucleation of protein pathology 
in human patients resulting in the sequestration of functional TDP-43 in cytoplasmic inclusions 
(Vanden Broeck et al. 2014). In cortical tissue from human FTLD patients, a disease that frequently 
presents with TDP-43 protein pathology, TDP-43 protein specifically loses its interaction with TE-
derived RNA transcripts, while its interaction with the majority of its other RNA binding partners is 
left largely intact. Intriguingly, there is a general concordance between the TE families that lose their 
interaction with TDP-43 in cortical tissue of human FTLD patients, and those whose transcription 
increases in brain tissue of rodent TDP-43 pathology models (Li et al. 2012). While these 
observations suggest that TDP-43 pathology may involve loss of suppression of TEs, it would take  
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the genetic tools available in a more tractable model organism to understand why this would be the 
case and whether this effect has an impact on cellular toxicity and physiological health. 
The absolute levels of the two major effector molecules of the siRNA system in Drosophila, 
DCR-2 and Ago2 (Figure 3), do not appear to be affected by hTDP-43 expression in either neurons or 
glia. However, implementation of a functional genetic reporter system demonstrates that hTDP-43 
expression causes erosion of the ability of the siRNA system to silence a transgenic reporter in vivo in 
both CNS neurons and glial cells that express hTDP-43. This suggests that hTDP-43 functionally 
impairs the siRNA system, and the robust and early effect observed here in glial cells is consistent 
with the early and aggressive expression of the gypsy RTE observed in head tissue of flies expressing 
hTDP-43 in glia. In neuronal structures, loss of siRNA silencing appears more gradual over age, with 
a later age of onset. While the precise factor that induces nucleation of TDP-43 pathology in 
otherwise genetically normal individuals is still not fully understood, it does happen. And when it 
does, these observations suggest that the effectiveness of siRNA silencing begins to be rapidly 
degraded in effected cells (Figure 27B: 6). This means that the siRNA system swiftly loses its ability 
to compensate for on-going loss of heterochromatic silencing of TEs, resulting in a precipitously brief 
window (Figure 27B: 7) between the onset of protein pathology and the inflection point at which TE 
activity overwhelms the system (Figure 27B: 8). This feature of the model is in fact reflected by the 
alarmingly rapid prognosis for an individual diagnosed with ALS, as most patients are expected to 
succumb to the disease within 3-5 years of the onset of symptoms (Ravits and La Spada 2009). 
Moreover, there is compelling feedback between the siRNA system and heterochromatin (as 
discussed in the Introduction) that could conceivably accelerate this process (Castel and Martienssen 
2013), and the kinetics of decline may be further exacerbated by the exponential function of 
activating multi-copy, self-replicating mobile elements. Taken in this light, the onset of symptoms in 
TDP-43 protein pathologies reflects two “hits” with regard to suppression of TEs: the first being 
normal age-related decline of heterochromatic suppression and the second being the rapid loss of 
siRNA silencing induced by the onset of TDP-43 protein pathology. The ensuing swift decline in the  
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health of an individual affected with TDP-43 protein pathology relates to the concomitant 
deterioration of both of these mechanisms and the self-multiplying functionality inherent to the 
resulting activation of TEs. 
The direct predictions of this model are that TDP-43 pathology will: a) result in loss of 
suppression of TEs, and that this loss of control of TEs will b) negatively influence measures of 
physiological health and c) drive cellular toxicity. As described above, manipulating TDP-43 in 
rodent cortical tissue results in increased expression of many different TEs (Li et al. 2012). In 
Drosophila, overexpressing hTDP-43 in glia results in dramatic, early induction of the gypsy ERV at 
both the RNA and protein level. This effect turns on post-developmentally and stochastically in the 
brains of flies expressing hTDP-43 in glia and both lifespan and locomotor behavior are drastically 
reduced in these flies. Knocking down gypsy suppresses this severe lifespan deficit, strongly 
implicating gypsy RTE activity as causally contributing to the premature death induced by glial 
expression of hTDP-43 in Drosophila. Importantly, no rescue of the less severe lifespan deficit 
induced by neuronal expression of hTDP-43 is achieved by gypsy knock-down, which is consistent 
with the observation that neuronal expression of hTDP-43 does not elevate gypsy expression above 
wild type background levels at any given time point. These effects are in accordance with recent 
reports that knockout of the C. elegans TDP-43 ortholog results in broad accumulation of general TE-
derived RNA transcripts (Saldi et al. 2014) and that HERV-K, a human ERV of the gypsy family, is 
activated in a certain subset of patients with ALS (Douville et al. 2011; Li et al. 2015). Indeed, 
overexpression of just the ENV protein of HERV-K is capable of inducing progressive motor 
dysfunction in transgenic mice (Li et al. 2015). Therefore the first two direct predictions of the Two-
Hit Hypothesis model appear to be fulfilled, as TDP-43 pathology does indeed result in the loss of 
suppression of TEs in genetic models and subsequent TE activity contributes to deterioration of the 
physical health of the animal (Figure 28C). The final prediction of the model, regarding whether 
TDP-43-dependent TE activity contributes to cellular toxicity, is perhaps the most important question  
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to answer with respect to palliative care and treatment of human patients affected with TDP-43 
pathologies. 
The brains of flies expressing TDP-43 in glia display rampant apoptosis, both with TUNEL 
staining and at the level of TEM. This is in keeping with the current consensus that cells experiencing 
TDP-43 pathology in patient tissue die largely by apoptosis (Vanden Broeck et al. 2014). As 
described in the previous section, TE activity is well documented to induce prolific DNA damage. 
Importantly, I have demonstrated that knocking down loki, the Drosophila ortholog of Chk-2, 
completely alleviates the rampant apoptosis observed in the CNS of flies expressing TDP-43 in glia. 
Chk-2 is a DNA-damage response factor that signals cells to undergo apoptosis if DNA damage 
levels accumulate above a given threshold (Brodsky et al. 2004; Norbury and Zhivotovsky 2004), 
therefore loss of function of Chk-2 does not stop DNA damage from happening, it simply removes 
the ability of the cell to detect it and respond by undergoing programmed cell death (Brodsky et al. 
2004). Therefore, my results show that the apoptosis induced by glial expression of TDP-43 is in 
large part induced by Chk-2 signaling following DNA damage (Figure 28A - 28B and 28D – 28F). 
TE activity does appear to contribute at least in part to the DNA-damage mediated apoptosis observed 
in response to TDP-43 expression in glia, as knocking down gypsy partially alleviates the rampant 
apoptosis observed in the CNS of these animals. This set of observations is consistent with reports 
that transgenic expression of the HERV-K Env protein in mice results in loss of volume in the motor 
cortex and DNA damage (Li et al. 2015) (Figure 28C - 28D). DNA damage-mediated apoptosis 
appears to be relevant to the general physiological health of the animal as well, as loki knockdown 
completely rescues the lifespan deficits observed with both glial and neuronal hTDP-43 expression. 
The fact that loki knock-down more fully suppresses apoptosis observed in the CNS of flies 
expressing TDP-43 in glia, as well as more completely suppresses the lifespan deficit induced by both 
glial and neuronal expression of TDP-43, hints that other TEs beyond gypsy may contribute to TDP-
43 induced cellular and physiological toxicity via DNA damage-mediated apoptosis. This observation 
is consistent with previous findings that TDP-43 promiscuously interacts with many types of TEs and  
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FIGURE 28: A unifying model: schematic illustration of cellular toxicity in TDP-43 protein 
pathology. 
(A) In normal, healthy cells, TDP-43 is mainly localized to the nucleus. However, in individuals that 
experience TDP-43 pathology, around middle age or later cytoplasmic inclusions of TDP-43 nucleate 
and this is associated with clearance from the nucleus (B). This results in loss of siRNA silencing, 
which precipitates activation of TEs [see also: (Li et al. 2012) and (Saldi et al. 2014)] (C). TEs at 
least partially contribute to DNA damage [see also: (Li et al. 2015)]. (D), which in turn activates Chk-
2 signaling (E). Chk-2 signaling ultimately results in apoptosis (F). 
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that TDP-43 pathology results in broad de-repression of TEs (Li et al. 2012; Saldi et al. 2014), as well 
as my findings that expressing TDP-43 in both neurons and glia negatively affects measures of  
physiological health and general siRNA-mediated silencing. These results indicate that TDP-43-
dependent TE activity contributes at least in part to cellular toxicity, once again pointing to TEs a 
decisive antagonistic pleiotropic entity. 
 These findings stimulate several new lines of questioning. Is the siRNA system the only TE 
silencing system negatively affected by TDP-43 protein pathology? Does TDP-43 pathology affect 
biogenesis of siRNAs or localization of loaded RISC to TE transcripts? What role does TDP-43’s 
binding to TE-derived RNA transcripts play in this regard, and is there negative feedback between 
pathology-induced malfunction of the siRNA system and heterochromatic stifling of TE expression? 
Are different TEs indeed activated in response to TDP-43 pathology in different cell types, and is 
there something particular to glia in this respect? Does activation of RTEs and/or ERVs in particular, 
with their unique capacity for cellular exodus, contribute to non-cell autonomous spread of pathology 
in the prognosis of TDP-43 protein pathologies? Indeed, Li et al (2015) note that the localization of 
HERV-K Env protein to the neuronal cell body in post-mortem tissue from ALS patients would 
account nicely for the stereotyped anatomical spread of ALS from brain region to adjacent brain 
region, a pattern that is plainly distinct from that observed with the transsynaptic spread characteristic 
of rabies virus (Li et al. 2015). However many other transmissible agents remain possible, such as 
protein or RNA species transferred via exosomes or other types of secretion into extracellular fluid or 
direct cytoplasmic transfer. Of course, further confirmation of this model by probing for its signatures 
in post-mortem human patient samples remains to be performed, and is sure to be greatly informative. 
This subject is incredibly fertile, and has the capacity to shed exciting new information on basic 
mechanisms of CNS function and its deterioration in both normal aging and neurodegenerative 
disease. 
Direct investigation of the role of TEs in TDP-43 protein pathologies permitted the 
development of the models described above, which in turn begin to reveal a comprehensive picture of  
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the role of TEs in neurodegeneration and in the context of normal brain aging. In this picture we see 
that normal aging erodes the topology of activating and repressive genomic architecture, which in 
advanced age results in the eventual derepression and mobilization of TEs. As previously elaborated, 
this represents a classic case of George William’s antagonistic pleiotropy by these non-coding genetic 
elements. While their activity may have been selected for based on certain advantages they confer to 
the host during neurodevelopment and adult nervous system function, this also exposes them to being 
particularly sensitive to the relaxation of selective pressure observed in old age, an effect that is 
amplified in human populations that have been predominantly liberated from natural selection. To 
further exacerbate the issue the brain is enriched in post-mitotic cells, with neurons being some of the 
perdurable cells in the body, making it duly susceptible to the accrual of genetic damage from TEs 
accumulated over the lifetime of the organism. The damaging action of these unregulated TEs has 
operative consequences for brain function in advanced age, resulting in slow, monotonic decline over 
the post-reproductive lifespan of the individual. In neurodegeneration collectively, we observe an 
age-dependent malfunction in at least one of the multi-tiered, interleaved mechanisms the brain 
employs to maintain its precarious TE equilibrium. The timing, localization, and cell types of the 
brain that are primarily affected in this diverse suite of diseases are likely dictated by the specificity 
of the initial malfunctioning component or process. This effectively trips a wire, interrupting the 
convoluted, finely tuned waltz of genetic information within the neuron and prematurely liberating 
the reservoir of destructive potential represented by mobile elements. After this initial activating  
event, the majority of these diseases exhibit astonishingly rapid prognosis. At least in the case of 
TDP-43 protein pathologies we know that once this balance is disrupted, TE activity ultimately 
contributes to cellular toxicity and functional decline. 
In short, we hypothesize that the brain is singularly tuned to utilize TEs, which also renders it 
uniquely susceptible to their antagonistic pleiotropic activity in late age. This effect has been exposed 
in civilized human societies by advances in health care and technology that have artificially elevated 
median age and life expectancy, and may explain why we observe a suite of neurodegenerative  
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diseases separate from neurodevelopmental diseases. The development of the model of TDP-43 
protein pathology I have presented above was enabled by specific, mechanistic analysis regarding 
TDP-43’s effects on TEs and opens up new avenues for both palliative care and treatment of affected 
individuals. Given that TEs have now been implicated in such a wide variety of other 
neurodegenerative diseases, I believe that its underlying principles will likely prove beneficial to the 
understanding of the pathological prognosis of neurodegenerative disease in general. However, more 
specific analysis of each of these disorders will be required to determine the individual characteristics 
that may aid in the development of treatment. I believe that there is now sufficient evidence to 
consider TEs a fundamental antagonistic pleiotropic force in aging, and it seems foolish to continue to 
disregard them as we strive for better understanding and treatment for our aging population. 
 
IV. Looking Forward: 
 Before the cracking of the genetic code there was a noticeable focus among biologists on 
protein-coding genes. This was an obvious starting place as these units of genetic material have 
physical products that are tractable to see, purify, and study, and such study has been invaluable in 
understanding the structure and physiology of cells and organisms as a whole. However, the genomic 
revolution has provided us with infinitely more information regarding what makes living things the 
way they are, with protein coding and related untranslated exons comprising at most 2% of the human  
genome. Indeed, the CNEs we have discussed easily fall under the original definition of a gene as “a 
unit of heredity that is transferred from parent to offspring and determines some characteristic of the 
offspring.” And yet, most current techniques actively ignore or discard repetitive sequences that 
would allow us to elucidate further the role of TEs and related CNEs in both normal physiological 
function and disease mechanisms. The pronounced inter-individual variation in non-coding DNA 
renders GWAS ineffectual for this type of investigation. It is likely that such approaches could not 
reach enough statistical power to detect variable pathological polymorphisms in non-coding regions  
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even if they were embedded in conserved CNEs. Moreover, many GWAS take a candidate gene-
biased approach. Microarray techniques, unless otherwise specified, implicitly ignore non-coding 
sequence. Whole genome sequencing approaches capture all of the information, yet most choose to 
throw away the fraction represented by repetitive sequence - including that contributed by TEs - by 
repeat masking. While it was understandable that figuring out how to map reads back to the genome 
may have excluded some types in order to solve the problem in the beginning of the sequencing era, 
reliable methods now exist with which to map repetitive reads. The un-mined wealth of discarded 
information already in existence in published and publically accessible sequencing datasets is 
astounding, and could benefit us greatly in re-analysis. There is simply no need to continue to cling to 
our coding sequence bias. The time has come to stop ignoring transposable elements. 
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